0001695473
2018-01-01
2018-03-31
0001695473
2017-12-31
0001695473
2016-12-31
0001695473
2016-01-01
2016-12-31
0001695473
2015-12-31
0001695473
2014-07-30
2014-07-31
0001695473
great:SyliosMember
2016-12-16
0001695473
2017-02-22
0001695473
2017-03-09
2017-03-10
0001695473
2017-04-20
2017-04-21
0001695473
great:SyliosMember
2017-04-20
2017-04-21
0001695473
great:BudBankMember
2017-04-20
2017-04-21
0001695473
great:BudBankMember
2017-06-19
0001695473
great:XeraflopTechnologiesMember
2017-07-16
2017-07-17
0001695473
great:JimmyWayneAndersonMember
2017-03-09
2017-03-10
0001695473
great:MCAPMember
2017-07-16
2017-07-17
0001695473
great:MCAPMember
great:FirstPaymentMember
2017-07-16
2017-07-17
0001695473
great:MCAPMember
great:SecondPaymentMember
2017-07-16
2017-07-17
0001695473
great:MCAPMember
great:FinalPaymentMember
2017-07-16
2017-07-17
0001695473
great:MCAPMember
2017-07-16
2017-07-18
0001695473
great:SyliosMember
2017-03-10
0001695473
great:SyliosMember
2017-02-03
0001695473
great:SyliosMember
2017-02-02
2017-02-03
0001695473
great:NovemberTwentyTwoThousandAndEighteenMember
2017-01-01
2017-12-31
0001695473
srt:MinimumMember
2016-12-31
0001695473
srt:MaximumMember
2016-12-31
0001695473
us-gaap:ConvertibleNotesPayableMember
great:EmetCapitalPartnersLLCMember
2017-05-25
0001695473
us-gaap:ConvertibleNotesPayableMember
great:EmetCapitalPartnersLLCMember
2017-05-24
2017-05-25
0001695473
us-gaap:ConvertibleNotesPayableMember
great:EmetCapitalPartnersLLCMember
2017-09-14
0001695473
us-gaap:ConvertibleNotesPayableMember
great:EmetCapitalPartnersLLCMember
2017-09-13
2017-09-14
0001695473
great:EmetCapitalPartnersLLCMember
2017-09-13
2017-09-14
0001695473
great:EmetCapitalPartnersLLCMember
2017-09-14
0001695473
great:ConvertiblePromissoryNoteOneMember
2017-12-31
0001695473
great:ConvertiblePromissoryNoteOneMember
2016-12-31
0001695473
great:ConvertiblePromissoryNoteTwoMember
2017-12-31
0001695473
great:ConvertiblePromissoryNoteTwoMember
2016-12-31
0001695473
great:ConvertiblePromissoryNoteThreeMember
2017-12-31
0001695473
great:PromissoryNoteOneMember
2018-03-31
0001695473
great:PromissoryNoteOneMember
2017-12-31
0001695473
great:PromissoryNoteTwoMember
2018-03-31
0001695473
great:PromissoryNoteTwoMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
2017-12-31
0001695473
us-gaap:WarrantMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesOneMember
2018-03-31
0001695473
great:ConvertiblePromissoryNotesOneMember
2016-12-31
0001695473
great:WarrantsOneMember
2018-03-31
0001695473
great:WarrantsOneMember
2016-12-31
0001695473
great:ConvertiblePromissoryNotesTwoMember
2018-03-31
0001695473
great:ConvertiblePromissoryNotesTwoMember
2016-12-31
0001695473
great:WarrantsTwoMember
2018-03-31
0001695473
great:WarrantsTwoMember
2016-12-31
0001695473
great:SyliosCorpMember
2017-01-01
2017-12-31
0001695473
great:SyliosCorpMember
2017-03-10
0001695473
great:SyliosCorpMember
2017-02-02
2017-02-03
0001695473
great:SyliosCorpMember
2017-02-03
0001695473
great:ConsultingFirmMember
2017-01-01
2017-03-31
0001695473
2017-01-01
2017-03-31
0001695473
us-gaap:ChiefExecutiveOfficerMember
2017-01-01
2017-03-31
0001695473
great:ThirdPartyMember
2017-09-13
2017-09-15
0001695473
great:EmetCapitalPartnersLLCMember
2017-05-25
0001695473
great:EmetCapitalPartnersLLCMember
2017-05-24
2017-05-25
0001695473
great:EmetCapitalPartnersLLCMember
2017-09-14
0001695473
great:EmetCapitalPartnersLLCMember
2017-09-13
2017-09-14
0001695473
great:BoardofDirectorsServiceAgreementMember
great:WayneAndersonMember
2017-01-01
2017-12-31
0001695473
great:BoardofDirectorsServiceAgreementMember
great:WayneAndersonMember
2017-10-01
2017-12-31
0001695473
us-gaap:ChiefExecutiveOfficerMember
2017-12-31
0001695473
us-gaap:ChiefExecutiveOfficerMember
2016-12-31
0001695473
great:SyliosCorpandTwoSubsidiariesofSyliosCorpMember
2017-12-31
0001695473
us-gaap:OfficerMember
2018-01-01
2018-03-31
0001695473
us-gaap:OfficerMember
2017-01-01
2017-03-31
0001695473
us-gaap:DirectorMember
2018-01-01
2018-03-31
0001695473
us-gaap:DirectorMember
2017-01-01
2017-03-31
0001695473
great:ConsultantMember
2018-01-01
2018-03-31
0001695473
great:ConsultantMember
2017-01-01
2017-03-31
0001695473
great:XeraflopTechnologiesMember
2017-07-17
0001695473
us-gaap:CommonStockMember
2017-01-01
2017-12-31
0001695473
us-gaap:CommonStockMember
2015-12-31
0001695473
us-gaap:CommonStockMember
2016-12-31
0001695473
us-gaap:CommonStockMember
2017-12-31
0001695473
us-gaap:AdditionalPaidInCapitalMember
2017-01-01
2017-12-31
0001695473
us-gaap:AdditionalPaidInCapitalMember
2015-12-31
0001695473
us-gaap:AdditionalPaidInCapitalMember
2016-12-31
0001695473
us-gaap:AdditionalPaidInCapitalMember
2017-12-31
0001695473
us-gaap:RetainedEarningsMember
2016-01-01
2016-12-31
0001695473
us-gaap:RetainedEarningsMember
2017-01-01
2017-12-31
0001695473
us-gaap:RetainedEarningsMember
2015-12-31
0001695473
us-gaap:RetainedEarningsMember
2016-12-31
0001695473
us-gaap:RetainedEarningsMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
2018-03-31
0001695473
us-gaap:WarrantMember
2018-03-31
0001695473
great:ConsultingFirmMember
2017-03-21
2017-03-22
0001695473
great:WayneAndersonMember
2017-01-01
2017-12-31
0001695473
2018-03-31
0001695473
2017-03-31
0001695473
great:MayTwoThousandAndNineteenMember
2018-01-01
2018-03-31
0001695473
us-gaap:ChiefExecutiveOfficerMember
2018-03-31
0001695473
great:SyliosCorpandTwoSubsidiariesofSyliosCorpMember
2018-03-31
0001695473
great:ConvertiblePromissoryNoteOneMember
2018-03-31
0001695473
great:ConvertiblePromissoryNoteTwoMember
2018-03-31
0001695473
great:ConvertiblePromissoryNoteThreeMember
2018-03-31
0001695473
great:PromissoryNoteMember
2018-03-31
0001695473
great:PromissoryNoteMember
2017-12-31
0001695473
great:ConvertiblePromissoryNoteOneMember
great:EmetCapitalPartnersLLCMember
2017-05-25
0001695473
great:ConvertiblePromissoryNoteOneMember
great:EmetCapitalPartnersLLCMember
2017-05-24
2017-05-25
0001695473
great:ConvertiblePromissoryNoteOneMember
great:EmetCapitalPartnersLLCMember
2018-03-31
0001695473
great:ConvertiblePromissoryNoteTwoMember
great:EmetCapitalPartnersLLCMember
2017-09-14
0001695473
great:ConvertiblePromissoryNoteTwoMember
great:EmetCapitalPartnersLLCMember
2017-09-13
2017-09-14
0001695473
great:ConvertiblePromissoryNoteTwoMember
great:EmetCapitalPartnersLLCMember
2018-03-31
0001695473
great:ConvertiblePromissoryNoteThreeMember
great:EmetCapitalPartnersLLCMember
2018-01-08
2018-01-09
0001695473
great:ConvertiblePromissoryNoteThreeMember
great:EmetCapitalPartnersLLCMember
2018-01-09
0001695473
great:ConvertiblePromissoryNoteThreeMember
great:EmetCapitalPartnersLLCMember
2018-03-31
0001695473
great:PromissoryNoteMember
great:JohnT.RootMember
2017-03-28
0001695473
great:PromissoryNoteMember
great:JohnT.RootMember
2017-03-27
2017-03-28
0001695473
great:PromissoryNoteOneMember
2016-12-31
0001695473
great:PromissoryNoteTwoMember
2018-01-01
2018-03-31
0001695473
great:ConvertiblePromissoryNotesThreeMember
2018-03-31
0001695473
great:ConvertiblePromissoryNotesFourMember
2018-03-31
0001695473
great:WarrantsThreeMember
2018-03-31
0001695473
great:SyliosCorpMember
2017-03-09
2017-03-10
0001695473
great:EmetCapitalPartnersLLCMember
2018-03-28
0001695473
great:EmetCapitalPartnersLLCMember
2018-03-26
2018-03-28
0001695473
great:WayneAndersonMember
2018-01-01
2018-03-31
0001695473
great:BoardofDirectorsServiceAgreementMember
great:WayneAndersonMember
2018-01-01
2018-03-31
0001695473
great:WaiverNoteMember
2018-01-09
0001695473
great:EmetCapitalPartnersLLCMember
2018-03-27
2018-03-28
0001695473
great:EmetCapitalPartnersLLCMember
2018-03-28
0001695473
great:EmetCapitalPartnersLLCMember
great:DebtentureMember
2018-03-28
0001695473
great:EmetCapitalPartnersLLCMember
great:AllongeMember
2018-03-28
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputExercisePriceMember
2018-03-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputExpectedTermMember
srt:MaximumMember
2018-01-01
2018-03-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
2018-01-01
2018-03-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2018-01-01
2018-03-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2018-01-01
2018-03-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputExercisePriceMember
2018-03-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputExpectedTermMember
srt:MinimumMember
2018-01-01
2018-03-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputExpectedTermMember
srt:MaximumMember
2018-01-01
2018-03-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputPriceVolatilityMember
2018-01-01
2018-03-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputExpectedTermMember
srt:MinimumMember
2018-01-01
2018-03-31
0001695473
us-gaap:ConvertibleDebtSecuritiesMember
2018-01-01
2018-03-31
0001695473
great:OutstandingWarrantsMember
2018-01-01
2018-03-31
0001695473
2017-12-21
2017-12-22
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2018-01-01
2018-03-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2018-01-01
2018-03-31
0001695473
great:ConvertiblePromissoryNoteFourMember
2018-03-31
0001695473
great:ConvertiblePromissoryNoteFourMember
2017-12-31
0001695473
great:ConvertiblePromissoryNoteFourMember
great:EmetCapitalPartnersLLCMember
2018-03-27
2018-03-28
0001695473
great:ConvertiblePromissoryNoteFourMember
great:EmetCapitalPartnersLLCMember
2018-03-28
0001695473
2017-01-01
2017-12-31
0001695473
great:ConvertiblePromissoryNoteOneMember
great:EmetCapitalPartnersLLCMember
2017-12-31
0001695473
great:ConvertiblePromissoryNoteTwoMember
great:EmetCapitalPartnersLLCMember
2017-12-31
0001695473
us-gaap:ChiefExecutiveOfficerMember
2017-03-30
2017-03-31
0001695473
great:ThirdPartyMember
2017-09-12
2017-09-15
0001695473
great:ConvertiblePromissoryNotesOneMember
2017-12-31
0001695473
great:WarrantsOneMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesTwoMember
2017-12-31
0001695473
great:WarrantsTwoMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesThreeMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesFourMember
2017-12-31
0001695473
great:WarrantsThreeMember
2017-12-31
0001695473
great:BoardofDirectorsServiceAgreementMember
great:WayneAndersonMember
2018-03-31
0001695473
great:BoardofDirectorsServiceAgreementMember
great:WayneAndersonMember
2017-12-31
0001695473
great:WayneAndersonMember
2018-03-31
0001695473
great:WayneAndersonMember
2017-12-31
0001695473
srt:MinimumMember
2017-12-31
0001695473
srt:MaximumMember
2017-12-31
0001695473
us-gaap:OfficerMember
2017-01-01
2017-12-31
0001695473
us-gaap:OfficerMember
2016-01-01
2016-12-31
0001695473
us-gaap:DirectorMember
2017-01-01
2017-12-31
0001695473
us-gaap:DirectorMember
2016-01-01
2016-12-31
0001695473
great:ConsultantMember
2017-01-01
2017-12-31
0001695473
great:ConsultantMember
2016-01-01
2016-12-31
0001695473
us-gaap:ConvertibleNotesPayableMember
2017-01-01
2017-12-31
0001695473
us-gaap:WarrantMember
2017-01-01
2017-12-31
0001695473
great:ArtemisMember
2017-01-01
2017-12-31
0001695473
great:ArtemisMember
great:ExecutionofAgreementMember
great:AugustTwoThousandFourteenMember
2017-01-01
2017-12-31
0001695473
great:ArtemisMember
great:SixtyDaysMember
2017-01-01
2017-12-31
0001695473
great:ArtemisMember
great:UponDelieveryOfPrototypeMember
2017-01-01
2017-12-31
0001695473
great:ArtemisMember
great:AfterDelieveryOfPrototypeMember
2017-01-01
2017-12-31
0001695473
great:PromissoryNoteTwoMember
2016-12-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputExercisePriceMember
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputExpectedTermMember
srt:MinimumMember
2017-01-01
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputExpectedTermMember
srt:MaximumMember
2017-01-01
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputPriceVolatilityMember
2017-01-01
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2017-01-01
2017-12-31
0001695473
great:ConvertiblePromissoryNotesMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2017-01-01
2017-12-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputExercisePriceMember
2017-12-31
0001695473
us-gaap:WarrantMember
srt:MinimumMember
us-gaap:MeasurementInputExpectedTermMember
2017-01-01
2017-12-31
0001695473
us-gaap:WarrantMember
srt:MaximumMember
us-gaap:MeasurementInputExpectedTermMember
2017-01-01
2017-12-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputPriceVolatilityMember
2017-01-01
2017-12-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MinimumMember
2017-01-01
2017-12-31
0001695473
us-gaap:WarrantMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
srt:MaximumMember
2017-01-01
2017-12-31
0001695473
great:SyliosCorpMember
2017-12-31
0001695473
great:WayneAndersonMember
2017-01-01
2017-03-31
0001695473
great:WaiverAgreementMember
great:WaiverNoteMember
2018-01-09
0001695473
great:EmetCapitalPartnersLLCMember
2018-03-27
2018-03-28
0001695473
great:EmetCapitalPartnersLLCMember
great:DebtentureMember
2018-03-28
0001695473
great:EmetCapitalPartnersLLCMember
great:AllongeMember
2018-03-28
0001695473
great:SyliosCorpandTwoSubsidiariesofSyliosCorpMember
2016-12-31
0001695473
great:PromissoryNoteMember
2016-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
great:Integer
Greater Cannabis Company, Inc.
POS AM
2018-03-31
true
Smaller Reporting Company
993
993
750
993
993
993
0
993
61241
66918
12500
12500
11578
7027
13143
65917
100000
61360
61360
4557
4557
65917
100000
37574
59553
375
375
391615
108788
476918
29381
26906
29381
495994
-26906
495994
-915997
-108788
-1001300
-390622
-108788
-5788
26906
26906
29381
-26906
-26906
495994
-5788
-108788
-915997
-475925
993
0
993
10000000
10000000
10000000
5000000
10000000
500000000
500000000
500000000
250000000
26905969
500000000
64
100
500000
500000
10000
10000
37500
10000
500000
500000
25000
25000
42500
7684
4557
42656
20184
100000
529557
622656
-20120
-100000
-529557
-622556
65183
3000
750
184653
-85303
-103000
-530307
-103000
-807209
-807209
-0.00
0.00
-0.02
-0.03
29380969
26905969
26946106
27978345
2500
15000
5000
5000
5000
525000
2500
0
500000
2500
0
0
25000
7500
10000
2500
532500
500000
0
7500
0
25000
0
3177
53741
-14443
-4557
-36315
4557
4557
2343
8141
12100
750
63250
14443
5307
37308
750
993
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE G - ISSUANCES OF COMMON STOCK AND WARRANTS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Common Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 10, 2017, in connection with
a partial spin-off of the Company from Sylios Corp, the Company issued a total of 26,905,969 shares of its common stock. 5,378,476
shares were issued to Sylios Corp (representing 19.99% of the issued and outstanding shares of Company common stock after the spin-off)
and 21,527,493 shares were issued to the stockholders of record of Sylios Corp on February 3, 2017 on the basis of one share of
Company common stock for each 500 shares of Sylios Corp common stock held (representing 80.01% of the issued and outstanding shares
of Company common stock after the spin-off).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the spin-off, the Company was a wholly
owned subsidiary of Sylios Corp. The accompanying financial statements retroactively reflect the spin-off transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 22, 2017, the Company issued
100,000 shares of its common stock to a consulting firm entity for service rendered. The $25,000 estimated fair value of the 100,000
shares has been expensed as consulting fees in the three months ended March 31, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 31, 2017, the Company issued
2,000,000 shares of its common stock to our Chief Executive Officer, Wayne Anderson, for services rendered. The $500,000 estimated
fair value of the 2,000,000 shares has been expensed as officer compensation in the three months ended March 31, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective September 15, 2017, the Company issued
375,000 shares of its common stock to retire a Note Payable to a Third Party.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2017, the Company issued Emet Capital
Partners, LLC a warrant granting the holder the right to purchase 440,000 shares of the Company’s common stock at an exercise
price of $.50 for a term of 5-years. If at any time after the Initial Exercise Date, there is no effective registration statement
registering the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares by the Holder, then this
Warrant may also be exercised at the Holder’s election, in whole or in part, at such time by means of a “cashless exercise”.
The Holder of the warrant did not require that the Company register the common shares to be issued under the warrant in the Registration
Statement declared effective August 31, 2017. (Please <i>see</i> <b>NOTE D - NOTES PAYABLE TO THIRD PARTIES</b> for further
information).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 14, 2017, the Company issued Emet
Capital Partners, LLC a warrant granting the holder the right to purchase 110,000 shares of the Company’s common stock at
an exercise price of $.50 for a term of 5-years. If at any time after the Initial Exercise Date, there is no effective registration
statement registering the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares by the Holder,
then this Warrant may also be exercised at the Holder’s election, in whole or in part, at such time by means of a “cashless
exercise”. The Holder of the warrant did not require that the Company register the common shares to be issued under the warrant
in the Registration Statement declared effective August 31, 2017. (Please <i>see</i> <b>NOTE D - NOTES PAYABLE TO THIRD PARTIES </b>for
further information).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 28, 2018, the Company issued Emet
Capital Partners, LLC a warrant granting the holder the right to purchase 98,600 shares of the Company’s common stock at
an exercise price of $.50 for a term of 5-years. If at any time after the Initial Exercise Date, there is no effective registration
statement registering the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares by the Holder,
then this Warrant may also be exercised at the Holder’s election, in whole or in part, at such time by means of a “cashless
exercise”. The Holder of the warrant has not requested that the Company register the common shares to be issued under the
warrant. (Please <i>see</i> <b>NOTE D - NOTES PAYABLE TO THIRD PARTIES </b>for further information).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2018, the Company has three
warrants issued and outstanding granting the holders the right to purchase up to a total of 648,600 shares of its common stock.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE H - ISSUANCES OF COMMON STOCK AND WARRANTS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common Stock</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 10, 2017, in connection with
a partial spin-off of the Company from Sylios Corp, the Company issued a total of 26,905,969 shares of its common stock. 5,378,476
shares were issued to Sylios Corp (representing 19.9% of the issued and outstanding shares of Company common stock after the spin-off)
and 21,527,493 shares were issued to the stockholders of record of Sylios Corp on February 3, 2017 on the basis of one share of
Company common stock for each 500 shares of Sylios Corp common stock held (representing 80.1% of the issued and outstanding shares
of Company common stock after the spin-off).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the spin-off, the Company was a wholly
owned subsidiary of Sylios Corp. The accompanying financial statements retroactively reflect the spin-off transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 22, 2017, the Company issued
100,000 shares of its common stock to a consulting firm entity for service rendered. The $25,000 estimated fair value of the 100,000
shares has been expensed as consulting fees in the three months ended March 31, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 31, 2017, the Company issued
2,000,000 shares of its common stock to our Chief Executive Officer, Wayne Anderson, for services rendered. The $500,000 estimated
fair value of the 2,000,000 shares has been expensed as officer compensation in the three months ended March 31, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective September 15, 2017, the Company issued
375,000 shares of its common stock to retire a Note Payable to a Third Party.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2017, the Company issued Emet Capital
Partners, LLC a warrant granting the holder the right to purchase 440,000 shares of the Company’s common stock at an exercise
price of $.50 for a term of 5-years. If at any time after the Initial Exercise Date, there is no effective registration statement
registering the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares by the Holder, then this
Warrant may also be exercised at the Holder’s election, in whole or in part, at such time by means of a “cashless exercise”.
The Holder of the warrant did not require that the Company register the common shares to be issued under the warrant in the Registration
Statement declared effective August 31, 2017. (Please <i>see</i> <b>NOTE E - NOTES PAYABLE TO THIRD PARTIES</b> for further information).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 14, 2017, the Company issued
Emet Capital Partners, LLC a warrant granting the holder the right to purchase 110,000 shares of the Company’s common stock
at an exercise price of $.50 for a term of 5-years. If at any time after the Initial Exercise Date, there is no effective registration
statement registering the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares by the Holder,
then this Warrant may also be exercised at the Holder’s election, in whole or in part, at such time by means of a “cashless
exercise”. The Holder of the warrant did not require that the Company register the common shares to be issued under the
warrant in the Registration Statement declared effective August 31, 2017. (Please <i>see</i> <b>NOTE E - NOTES PAYABLE TO THIRD
PARTIES </b>for further information).</p>
0.1999
0.1999
0.801
0.1999
0.8001
0.199
10000
2000
498000
500000
10000
100000
2000000
100000
2000000
2000000
0.10
0.03
0.12
2018-06-30
2018-05-25
2018-09-14
2018-05-25
2018-09-14
2019-01-09
2017-09-28
2017-09-30
2018-09-14
2018-09-14
2018-09-14
0.20
5378476
21527493
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The derivative liability at March 31, 2018
and December 31, 2017 consisted of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">58,168</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">65,868</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note dated May 25, 2017. Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">95,260</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">96,580</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">16,929</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">18,381</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note dated September 14, 2017. Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">24,288</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">24,574</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Convertible Promissory Note dated January 9, 2018 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">27,296</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Allonge dated March 28, 2018 to the Convertible Promissory Note dated September 14, 2017 Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">14,898</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Allonge dated March 28, 2018 to the Convertible Promissory Note dated September 14, 2017. Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">22,303</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total derivative liability</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">259,142</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">205,403</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The derivative liability at December 31, 2017
consisted of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">65,868</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note. Please <i>see</i> <b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">96,580</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">18,381</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note. Please <i>see</i> <b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">24,574</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">          -</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total derivative liability</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">205,403</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s deferred taxes as of March
31, 2018 and December 31, 2017 consist of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt; text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Non-Current deferred tax asset:</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"> </td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Net operating loss carry-forwards (a)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">28,096</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">19,867</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance (a)</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(28,096</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(19,867</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Net non-current deferred tax asset</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"> </p>
<p style="margin: 0pt"></p>
<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 24px; font: 12pt Times New Roman, Times, Serif"> </td>
<td style="width: 24px; font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt">(a)</font></td>
<td style="font: 12pt Times New Roman, Times, Serif; text-align: justify"><font style="font-size: 10pt">As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate was changed to 21% effective January 1, 2018. Accordingly, we reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $13,245 from $33,112 to $19,867 as of December 31, 2017.</font></td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s deferred taxes as of December
31, 2017 and December 31, 2016 consist of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Net operating loss carry-forwards</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">42,713</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">38,076</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(42,713</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(38,076</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Net non-current deferred tax asset</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
<p style="margin: 0pt"></p>
55000
13750
100000
55000
13750
20000
28500
20000
25850
13750
12100
25850
20000
13750
14750
440000
110000
440000
110000
648600
440000
110000
98600
98600
98600
P5Y
P5Y
P5Y
P5Y
P5Y
P5Y
0.50
0.50
0.50
0.50
0.50
0.50
0.50
.50
0.50
21638
142903
21980
37199
9902
1761
7040
1477
2862
12245
9203
3042
284
12500
37500
1565
3000
750
4551
1565
3000
750
4551
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE D - NOTES PAYABLE TO THIRD PARTIES
</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to third parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due May 25, 2018-less unamortized debt discount of $7,987 and $21,849 at March 31, 2018 and December 31, 2017, respectively (i)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">47,013</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,151</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due September 14, 2018-less unamortized debt discount of $6,236 and $9,702 at March 31, 2018 and December 31, 2017, respectively (ii)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">7,514</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,048</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Convertible Promissory Note dated January 9, 2018 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due January 9, 2019-less unamortized debt discount of $15,562 at March 31, 2018 (iii)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,438 </font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">- </font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Allonge to the Convertible Promissory Note dated September 14, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due September 14, 2018-less unamortized debt discount of $11,887 at March 31, 2018 (iv)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">213 </font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">- </font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Promissory Note dated March 28, 2017 payable to John T. Root, Jr., interest at 4%, due September 28, 2017, convertible into shares of common stock at a conversion price of $.001 per share.</font></td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">375</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">375</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Total</font></td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">59,553</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,574</font></td>
<td> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(i) On May 25, 2017, the Company executed a
Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $55,000 in exchange for $50,000 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (May 25, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the
lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up
to 440,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. As part of the Convertible
Note, the Company executed a Registration Rights Agreement (the “RRA”) dated May 25, 2017. Among other things, the
RRA provided for the Company to file a Registration Statement with the SEC covering the resale of shares underlying the Convertible
Note and the warrant and to have declared effective such Registration Statement. The Registration Statement was declared effective
by the Securities and Exchange Commission on August 31, 2017. Please <i>see </i><b>NOTE F - DERIVATIVE LIABILITY</b> for further
information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) On September 14, 2017, the Company executed
a Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $13,750 in exchange for $12,500 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (September 14, 2018) at the option of the holder at the Variable Conversion Price, which shall mean
the lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up
to 110,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please <i>see </i><b>NOTE
F - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(iii) On January 9, 2018, the Company executed
a Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $20,000 in exchange for entry into a Waiver Agreement pertaining to the Securities Purchase Agreements entered into between
the Parties dated May 25, 2017 and September 14, 2017 along with a Convertible Note issued by the Company on each of the same dates.
The Company received $0 cash from issuance of the Convertible Note. The Convertible Note is convertible, in whole or in part, at
any time and from time to time before maturity (January 9, 2019) at the option of the holder at the Variable Conversion Price,
which shall mean the lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price
(as defined). “Market Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty
(20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of
one (1) year and bears interest at 5% annually. Please <i>see </i><b>NOTE F - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(iv) On March 28, 2018, the Company made an
Allonge to the Convertible Debenture due September 14, 2018 (hereinafter the “Allonge”) to Emet Capital Partners,
LLC. The Principal Amount as stated on the face of the Debenture shall be increased to $25,850 ($13,750 – original Principal
Amount of the Debenture + $12,100 Allonge. The amendment to the Principal Amount due and owing on the Debenture described herein
notwithstanding, the Holder does not waive interest that may have accrued at a default rate of interest and liquidated damages,
if any, that may have accrued on the Debenture through the date of this Allonge, which default interest and liquidated damages,
if any, remain outstanding and payable. As part of the transaction, EMET was also issued a warrant granting the holder the right
to purchase up to 98,600 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please
<i>see </i><b>NOTE F - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE E - NOTES PAYABLE TO THIRD PARTIES
</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to third parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due May 25, 2018-less unamortized debt discount of $21,849 at December 31, 2017 (i)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,151</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due September 14, 2018-less unamortized debt discount of $9,702 at December 31, 2017 (ii)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,048</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Promissory Note dated March 28, 2017 payable to John T. Root, Jr., interest at 4%, due September 28, 2017, convertible into shares of common stock at a conversion price of $.001 per share.</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">375</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,574</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(i) On May 25, 2017, the Company executed a
Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $55,000 in exchange for $50,000 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (May 25, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the
lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up
to 440,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. As part of the Convertible
Note, the Company executed a Registration Rights Agreement (the “RRA”) dated May 25, 2017. Among other things, the
RRA provided for the Company to file a Registration Statement with the SEC covering the resale of shares underlying the Convertible
Note and the warrant and to have declared effective such Registration Statement. The Registration Statement was declared effective
by the Securities and Exchange Commission on August 31, 2017. Please <i>see </i><b>NOTE G - DERIVATIVE LIABILITY</b> for further
information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) On September 14, 2017, the Company executed
a Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $13,750 in exchange for $12,500 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (September 14, 2018) at the option of the holder at the Variable Conversion Price, which shall mean
the lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase
up to 110,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please <i>see </i><b>NOTE
G - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Loans payable to related parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Due to Chief Executive Officer</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,203</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">7,040</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Due to Sylios Corp and two subsidiaries of Sylios Corp</font></td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,042</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,862</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,245</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,902</font></td>
<td> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Loans payable to related parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Due to Chief Executive Officer</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">7,040</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,477</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Due to Sylios Corp and two subsidiaries of Sylios Corp</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,862</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">284</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,902</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,761</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to related party consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%"><font style="font-size: 10pt">Promissory Note dated August 12, 2014 payable to Sylios Corp, interest at 3%</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">61,360</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">61,360</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Promissory Note dated March 31, 2017 payable to Sylios Corp, interest at 3%, due September 30, 2017</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,557</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,557</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">65,917</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">65,917</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to related party consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Promissory Note dated August 12, 2014 payable to Sylios Corp, interest at 3%</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">61,360</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">100,000</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Promissory Note dated March 31, 2017 payable to Sylios Corp, interest at 3%, due September 30, 2017</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,557</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">65,917</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100,000</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
50000
5000
180000
180000
0001695473
205403
259142
.001
0.001
.001
0.001
0.001
0.001
29380969
26905969
29380969
0.05
0.05
0.03
0.03
0.03
0.05
0.05
0.05
0.04
0.03
0.05
62500
7987
6236
15562
11887
21849
9702
50000
12500
50000
12500
0.25
0.25
0.25
0.25
0.25
0.001
0.50
0.50
0.50
0.50
0.50
20
20
20
20
20
P1Y
P1Y
P1Y
P1Y
P1Y
0
0.25
0.25
0.25
0.25
205403
58168
95260
16929
24288
259142
27296
14898
22303
65868
96580
18381
24574
26905969
5378476
21527493
5378476
26905969
500
P5Y
P5Y
P5Y
P5Y
72
109
203395
133792
2037
2037
38076
38076
10000
10000
10000
136
209
P1Y
P50M
P5Y
P2M
0.125
0.50
1.61
1.61
0.0168
0.0201
0.0242
0.0256
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE A – NATURE OF OPERATIONS AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Nature of Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Greater Cannabis Company, Inc. (the “Company”)
was formed in March 2014 as a limited liability company under the name, The Greater Cannabis Company, LLC. The Company remained
a wholly owned subsidiary of Sylios Corp (“Sylios”) until March 2017. The Company’s business plan is to concentrate
on cannabis related investment and development opportunities through its online retail store, direct equity investments, joint
ventures, licensing agreements or acquisitions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s business model is divided
into four operating segments through the Company’s three wholly owned subsidiaries; Bud Bank, Inc., GCC Superstore, LLC and
GCC Investment Holdings, LLC:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <b>E-commerce</b>- Through the Company’s
wholly owned subsidiary, GCC Superstore, LLC, the Company has established an online store whose merchandise includes pipes, vaporizers,
grinders, hemp related products, CBD (Cannabidiol) related products and additional products focusing on the cannabis industry.
The online store, GCC Superstore, was opened in June 2017 and can be found at www.gccsuperstore.com. At present, the GCC Superstore
carries in excess of 1000 products from 20 suppliers and over 50 brands. The online store operates under a “drop-ship”
model which affords it the benefit of less capital expenditure on inventory. Please <i>see </i><b>NOTE J - SUBSEQUENT EVENTS </b>for
further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. <b>Advertising</b>- With the development
of the GCC Superstore, the Company will place directed advertising throughout the online store. Advertising will originate through
Google AdSense or direct-advertising sales by the Company. The company will also use social media outlets such as Facebook, Twitter
and Instagram in an effort to attract customers with product specific advertisements or posts.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <b>Licensing</b>- The Company is actively
seeking licensing opportunities in the cannabis sector, for intellectual property, products and dispensary means. At present, the
Company does not have any active licensing agreements. On July 31, 2014, the Company entered into a Licensing Agreement with Artemis
Dispensing Technologies for the development and resell of an automated dispensing product. Under the collaboration and license
agreement, Artemis was to be responsible for the development of a high end automated dispensing product. Upon launch and sales
of the product, Artemis was to be responsible for the installation, training and customer support for the hardware and software.
The Company was to be responsible for direct sales, addition of key distributors and sublicensing of specific territories within
the U.S. The initial term of the Agreement expired December 31, 2016 and in the opinion of management the Agreement is no longer
in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. <b>Direct Investments</b>- The Company may,
at its election, directly invest in private entities within the cannabis sector either through stock purchase agreements, debentures,
joint ventures or a hybrid of each through its wholly owned subsidiary GCC Investment Holdings, LLC. The Company’s planned
investments will focus on those entities whose near-term goals are to maximize shareholder value through the filing of an initial
public offering or a corporate event that takes the entity from private to public.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 16, 2016, Sylios Corp’s Board
of Directors voted to file a Notice of Conversion for its wholly owned subsidiary, The Greater Cannabis Company, LLC. The Notice
was filed with the State of Florida Division of Corporations on January 13, 2017 to convert The Greater Cannabis Company, LLC from
a limited liability company to a Florida for-profit corporation. The company name, The Greater Cannabis Company, LLC, was changed
to The Greater Cannabis Company, Inc. Included within the filing, The Greater Cannabis Company, Inc. filed its Articles of Incorporation
and authorized 500 million shares of Common stock and 10 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new entity, GCC Superstore, LLC. The Articles of Organization were
filed with the State of Florida on January 13, 2017 with a requested effective date of January 9, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 18, 2017, Sylios Corp filed a corporate
action with the Financial Industry Regulatory Authority (“FINRA”) to effect a partial spin-off of its wholly owned
subsidiary, The Greater Cannabis Company, Inc, through a stock dividend. Please <i>see</i> <b>NOTE A- NATURE OF OPERATIONS AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)</b> for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2017, the Company and Sylios
Corp. entered into a Anti-Dilution Agreement whereby at any time after the date of the Agreement, if the Company shall issue or
propose to issue any additional shares of the Company’s common stock, or warrants, options (excluding any options granted
to employees of the Company in accordance with any employee plans, now or hereinafter in effect) or other rights or instruments
of any kind convertible into or exercisable or exchangeable for shares of Common Stock, Sylios Corp. shall have the right to subscribe
for and to purchase at the same price per share that number of Additional Securities necessary to maintain a Fully-Diluted Ownership
Percentage of 19.99% of the Company’s issued and outstanding Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 7, 2017, Sylios Corp received notification
from the Financial Industry Regulatory Authority (“FINRA”) that they had received the necessary documentation to process
the corporate action requested by Sylios Corp and its transfer agent, Pacific Stock Transfer. The Company’s Payment Date
was set at March 10, 2017 and the distribution(s) were made consistent with such approval.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 10, 2017, the Company entered into
a Board of Directors Service Agreement with Jimmy Wayne Anderson to define the Director’s duties and compensation for serving
on the Company’s Board of Directors. Under the terms of the Agreement, the Director is to receive compensation in the amount
of Ten Thousand dollars ($10,000) and 10,000 shares of the Company’s common stock payable on the last calendar day of each
quarter as long as Director continues to fulfill his duties and provides the services required.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2017, the Company entered into
a Collateral Agreement with Sylios Corp (“Borrower”) and SLMI Energy Holdings, LLC (“Lender”) whereby the
Company was released from any guaranty of the debt between Borrower and Lender.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2017, the Company entered into
a definitive Asset Acquisition Agreement (the “Agreement”) with Sylios Corp (“Sylios”), whereby the Company
acquired Sylios’ wholly owned subsidiary Bud Bank, LLC (“Bud Bank”). Under the Agreement, the Company is obligated
to pay Sylios a royalty of 10% of net sales proceeds generated by Bud Bank through its operations up to a total of $50,000 and
thereafter for perpetuity pay a royalty of 3% of net sales proceeds generated by Bud Bank through its operations. The transaction
closed on June 20, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">   </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2017, we launched our online store,
GCC Superstore, with limited merchandise such as pipes, vaporizers, CDB, hemp and cannabis related products.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 19, 2017, a Notice of Conversion was
filed for Bud Bank, LLC to effectively convert Bud Bank, LLC from a limited liability company to a Florida for-profit corporation.
The company name, Bud Bank, LLC, was changed to Bud Bank, Inc. Included within the filing, Bud Bank, Inc. filed its Articles of
Incorporation and authorized 250 million shares of Common stock and 5 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
a Convertible Promissory Note and Warrant and Subscription Agreement with Xeraflop Technologies, Inc. (“Xeraflop”).
Under the terms of the Agreement, the Company was to invest a total of One Hundred Thousand Dollars ($100,000) upon a successful
going public event. The Note was to accrue interest at 12% annually and mature on June 30, 2018. At the Company’s election,
the principal and interest could be converted into Series 2 common shares of Xeraflop with written notice. The Company was also
granted the right to purchase 20% warrant coverage based on the Company’s principal investment with a strike price equivelant
to the equity round financing. The Company’s investment in Xeraflop was dependent on the Company obtaining an effective Registration
Statement and successful 15C211 filing prior to the Closing of the financing round by Xeraflop. In the event neither of these events
occurred, the Company was not to be able to participate in this round of financing with Xeraflop. The Xeraflop financing round
closed prior to the Company receiving notification of its trading status. Therefore, the Company was not able to participate in
this round of financing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
an Advisory Agreement with MCAP, LLC (“MCAP”), whereby MCAP will act as the Company’s advisor in connection with
quoting the Company’s securities on OTCQB or OTCQX, Under the terms of the Agreement, the advisor’s services will include
rendering advice to the Company with respect to eligibility for becoming quoted on the OTCQB/OTCQX and educating, advising and
assisting the Company in complying with its ongoing OTCQB/OTCQX disclosure obligations under current federal and state securities
laws. The Company is to compensate MCAP a total of $15,000 with the first payment of $5,000 to be made upon execution of the Advisory
Agreement, the second payment of $5,000 to be made on or before August 2, 2017 and the final payment of $5,000 to be made upon
the Company’s acceptance on OTCQB/OTCQX. The Company made the initial payment of $5,000 on July 18, 2017. The Company has
not made the second or third payments due to MCAP, but the Agreement entered into between the parties is still in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 20, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new Florida limited liability company, GCC Investment Holdings, LLC.
The Articles of Organization were filed with the State of Florida on July 20, 2017. The new entity is a wholly owned subsidiary
of The Greater Cannabis Company, Inc. and will serve as the Company’s subsidiary to enter into direct cannabis related investments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2018, the Company and Emet Capital
Partners, LLC (collectively, the “Parties”) entered into a Waiver Agreement pertaining to the Securities Purchase Agreements
entered into between the Parties dated May 25, 2017 and September 14, 2017 along with a Convertible Note issued by the Company
on each of the same dates (the “Notes”). Under the terms of the May 25, 2017 Note, the Company was to have a Going
Public Event no later than August 27, 2017. As of the date of the Waiver, the Company has failed to be quoted on an exchange. Under
the terms of the Waiver, the Company issued the Holder of the Notes a new Note (the “Waiver Note”) in the amount of
$20,000 and the Holder waived the event of default solely as related to timely have a Going Public Event. The Company did not receive
any funds for the issuance of the Waiver Note.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 28, 2018, the Company made an Allonge
to Emet Capital Partners, LLC to the Note due on September 14, 2018 and issued by the Company on September 14, 2017. The Principal
Amount as stated on the face of the Debenture shall be increased to $25,850.00 ($13,750.00 – original Principal Amount of
the Debenture + $12,100.00 Allonge hereto the “New Principal”). The amendment to the Principal Amount due and owing
on the Debenture described herein notwithstanding, Holder does not waive interest that may have accrued at a default rate of interest
and liquidated damages, if any, that may have accrued on the Debenture through the date of this Allonge, which default interest
and liquidated damages, if any, remain outstanding and payable. As part of the transaction, EMET was also issued a warrant granting
the holder the right to purchase up to 98,600 shares of the Company’s common stock at an exercise price of $.50 for a term
of 5-years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Spin-Off</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 10, 2017, in connection with
a partial spin-off of the Company from Sylios Corp, the Company issued a total of 26,905,969 shares of its common stock. 5,378,476
shares were issued to Sylios Corp (representing 19.99% of the issued and outstanding shares of Company common stock after the spin-off)
and 21,527,493 shares were issued to the stockholders of record of Sylios Corp on February 3, 2017 on the basis of one share of
Company common stock for each 500 shares of Sylios Corp common stock held (representing 80.01% of the issued and outstanding shares
of Company common stock after the spin-off).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of The Greater Cannabis Company, Inc., and all of its wholly owned subsidiaries, Bud Bank, Inc., GCC Superstore, LLC
and GCC Investment Holdings, LLC. On March 10, 2017, the Company was spun-off from its former parent company, Sylios Corp, in a
stock dividend. Please <i>see</i> <b>NOTE A- NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off) </b>for
further information. All intercompany accounts and transactions have been eliminated in consolidation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying interim unaudited financial
statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”)
for interim financial statements and in the opinion of management contain all adjustments (consisting of only normal recurring
adjustments) necessary to present fairly, in all material respects, the Company’s consolidated financial position as of March
31, 2018, and the results of its operations for the three months ended March 31, 2018 and 2017 and cash flows for the three months
ended March 31, 2018 and 2017. These statements reflect all normal and recurring adjustments that, in the opinion of management,
are necessary for a fair presentation of the information contained herein. The results of operations for the interim periods are
not necessarily indicative of the results that might be expected for future interim periods or for the full year ending December
31, 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investments having an original maturity of
90 days or less that are readily convertible into cash are considered to be cash equivalents. For the periods presented, the Company
had no cash equivalents.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Income Taxes</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with Accounting Standards Codification
(ASC) 740 - Income Taxes, the provision for income taxes is computed using the asset and liability method. The asset and liability
method measures deferred income taxes by applying enacted statutory rates in effect at the balance sheet date to the differences
between the tax basis of assets and liabilities and their reported amounts on the financial statements. The resulting deferred
tax assets or liabilities are adjusted to reflect changes in tax laws as they occur. A valuation allowance is provided when it
is more likely than not that a deferred tax asset will not be realized.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We expect to recognize the financial statement
benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in
an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount to be recognized in the financial
statements will be the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the
threshold, no financial statement benefit is recognized. As of March 31, 2018, we had no uncertain tax positions. We recognize
interest and penalties, if any, related to uncertain tax positions as general and administrative expenses. We currently have no
federal or state tax examinations nor have we had any federal or state examinations since our inception. To date, we have not incurred
any interest or tax penalties.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results
could differ from those estimates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Financial Instruments and Fair Value of
Financial Instruments</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We adopted ASC Topic 820, <i>Fair Value Measurements
and Disclosures</i>, for assets and liabilities measured at fair value on a recurring basis. ASC Topic 820 establishes a common
definition for fair value to be applied to existing US GAAP that requires the use of fair value measurements that establishes a
framework for measuring fair value and expands disclosure about such fair value measurements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 820 defines fair value as the price that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. Additionally, ASC Topic 820 requires the use of valuation techniques that maximize the use of observable inputs
and minimize the use of unobservable inputs. These inputs are prioritized below:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 7%"><font style="font-size: 10pt">Level 1:</font></td>
<td style="width: 1%"> </td>
<td style="width: 92%; text-align: justify"><font style="font-size: 10pt">Observable inputs such as quoted market prices in active markets for identical assets or liabilities</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 2:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Observable market-based inputs or unobservable inputs that are corroborated by market data</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 3:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of financial assets and
liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured
on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and
liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. Except
for derivative liabilities, we had no financial assets or liabilities carried and measured on a recurring or nonrecurring basis
during the reporting periods.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Liabilities</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate stock options, stock warrants or
other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately
accounted for under the relevant sections of ASC Topic 815-40, <i>Derivative Instruments and Hedging: Contracts in Entity’s
Own Equity</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The result of this accounting treatment could
be that the fair value of a financial instrument is classified as a derivative instrument and is marked-to-market at each balance
sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is
recorded in the statement of operations as other income or other expense. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Financial instruments
that are initially classified as equity that become subject to reclassification under ASC Topic 815-40 are reclassified to a liability
account at the fair value of the instrument on the reclassification date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-lived Assets</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets such as property and equipment
and intangible assets are periodically reviewed for impairment. We test for impairment losses on long-lived assets used in operations
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability
of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash
flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s
estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated
by management which could have a material effect on our reporting results and financial positions. Fair value is determined through
various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals,
as considered necessary.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Website Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Website costs are expensed as incurred. For
the three months ended March 31, 2018 and 2017, website expense was $161 and $0, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Deferred Financing Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred financing costs represent costs incurred
in connection with obtaining debt financing. These costs are amortized ratably and charged to financing expenses over the term
of the related debt.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equity Instruments Issued to Non-Employees
for Acquiring Goods or Services</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Issuances of our common stock or warrants for
acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants
or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is
reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently
large disincentive for nonperformance) or (ii) the date at which performance is complete.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although situations may arise in which counter
performance may be required over a period of time, the equity award granted to the party performing the service may be fully vested
and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist if the instruments
are fully vested on the date of agreement, we determine such date to be the measurement date and will record the estimated fair
market value of the instruments granted as a prepaid expense and amortize such amount to expense over the contract period. When
it is appropriate for us to recognize the cost of a transaction during financial reporting periods prior to the measurement date,
for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock-Based Compensation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We account for share-based awards to employees
in accordance with ASC 718 “Stock Compensation”. Under this guidance, stock compensation expense is measured at the
grant date, based on the fair value of the award, and is recognized as an expense over the estimated service period (generally
the vesting period) on the straight-line attribute method. Share-based awards to non-employees are accounted for in accordance
with ASC 505-50 “Equity Based Payments to Non-Employees”, wherein such awards are expensed over the period in which
the related services are rendered.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Related Parties</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A party is considered to be related to us if
the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control
with us. Related parties also include our principal owners, our management, members of the immediate families of our principal
owners and our management and other parties with which we may deal if one party controls or can significantly influence the management
or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its
own separate interests. A party which can significantly influence the management or operating policies of the transacting parties,
or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that
one or more of the transacting parties might be prevented from fully pursuing its own separate interests, is also a related party.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales is recognized when
all of the following criteria are met: (1) persuasive evidence of an arrangement exists, (2) the price is fixed or determinable,
(3) collectability is reasonably assured, and (4) delivery has occurred.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Advertising Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
For the periods presented, we had no advertising costs.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss per Share</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute net loss per share in accordance
with FASB ASC 260. The ASC specifies the computation, presentation and disclosure requirements for loss per share for entities
with publicly held common stock.</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share amounts is computed by
dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed
on the basis of the weighted average number of common shares and dilutive securities (such as stock options, warrants and convertible
securities) outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the
calculation. For the period ended March 31, 2018, the Company excluded 1,181,800 shares relating to convertible notes payable to
third parties (Please <i>see</i> <b>NOTE D - NOTES PAYABLE TO THIRD PARTIES </b>for further information) and 648,600 shares relating
to outstanding warrants (Please <i>see </i><b>NOTE G - ISSUANCES OF COMMON STOCK AND WARRANTS</b> for further information) from
the calculation of diluted shares outstanding as the effect of their inclusion would be anti-dilutive.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recently Enacted Accounting Standards</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which supersedes nearly
all prior revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised
goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled
for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, more judgment
and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. As amended by
the FASB in July 2015, the standard is effective for annual periods beginning after December 15, 2017, and interim periods therein,
using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard
in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the
cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures).
ASU 2014-09 has had no impact on our Financial statements for the three months ended March 31, 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02,
Leases (Topic 842), to provide guidance on recognizing lease assets and lease liabilities on the balance sheet and disclosing key
information about leasing arrangements, specifically differentiating between different types of leases. The core principle of Topic
842 is that a lessee should recognize the assets and liabilities that arise from all leases. The recognition, measurement, and
presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous GAAP. There
continues to be a differentiation between finance leases and operating leases. However, the principal difference from previous
guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the balance sheet.
The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The amendments will be effective
for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is
permitted. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period
presented using a modified retrospective approach. The modified retrospective approach includes a number of optional practical
expedients that entities may elect to apply. These practical expedients relate to the identification and classification of leases
that commenced before the effective date, initial direct costs for leases that commenced before the effective date, and the ability
to use hindsight in evaluating lessee options to extend or terminate a lease or to purchase the underlying asset. An entity that
elects to apply the practical expedients will, in effect, continue to account for leases that commence before the effective date
in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset
and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental
payments that were tracked and disclosed under previous GAAP. The Company is currently evaluating the impact of ASU 2016-02 on
its future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-08,
Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, to clarify the implementation guidance
on principal versus agent considerations and address how an entity should assess whether it is the principal or the agent in contracts
that include three or more parties. The effective date and transition requirements for these amendments are the same as the effective
date and transition requirements of ASU 2014-09 (discussed above). ASU 2016-08 has had no impact on our Financial statements for
the three months ended March 31, 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2016, the FASB issued ASU No. 2016-10,
Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, to clarify the following
two aspects of Topic 606: 1) identifying performance obligations, and 2) the licensing implementation guidance. The effective
date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU 2014-09
(discussed above). ASU 2016-10 has had no impact on our Financial statements for the three months ended March 31, 2018.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE A – NATURE OF OPERATIONS AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Nature of Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Greater Cannabis Company, Inc. was formed
in March 2014 as a limited liability company under the name, The Greater Cannabis Company, LLC. The Company remained a wholly owned
subsidiary of Sylios Corp until March 2017. The Company’s business plan is to concentrate on cannabis related investment
and development opportunities through its online retail store, direct equity investments, joint ventures, licensing agreements
or acquisitions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s business model is divided
into four operating segments through the Company’s three wholly owned subsidiaries; Bud Bank, Inc., GCC Superstore, LLC and
GCC Investment Holdings, LLC:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <b>E-commerce</b>- Through the Company’s
wholly owned subsidiary, GCC Superstore, LLC, the Company has established an online store whose merchandise includes pipes, vaporizers,
grinders, hemp related products, CBD (Cannabidiol) related products and additional products focusing on the cannabis industry.
The online store, GCC Superstore, was opened in June 2017 and can be found at www.gccsuperstore.com. At present, the GCC Superstore
carries in excess of 1000 products from 20 suppliers and over 50 brands. The online store operates under a “drop-ship”
model which affords it the benefit of less capital expenditure on inventory. Please <i>see </i><b>NOTE K - SUBSEQUENT EVENTS </b>for
further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. <b>Advertising</b>- With the development
of the GCC Superstore, the Company will place directed advertising throughout the online store. Advertising will originate through
Google AdSense or direct-advertising sales by the Company. The company will also use social media outlets such as Facebook, Twitter
and Instagram in an effort to attract customers with product specific advertisements or posts.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <b>Licensing</b>- The Company is actively
seeking licensing opportunities in the cannabis sector, for intellectual property, products and dispensary means. At present, the
Company does not have any active licensing agreements. On July 31, 2014, the Company entered into a Licensing Agreement with Artemis
Dispensing Technologies for the development and resell of an automated dispensing product. Under the collaboration and license
agreement, Artemis was to be responsible for the development of a high end automated dispensing product. Upon launch and sales
of the product, Artemis was to be responsible for the installation, training and customer support for the hardware and software.
The Company was to be responsible for direct sales, addition of key distributors and sublicensing of specific territories within
the U.S. The initial term of the Agreement expired December 31, 2016 and in the opinion of management the Agreement is no longer
in effect. Please <i>see</i> <b>NOTE C- ARTEMIS LICENSING AGREEMENT</b> for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. <b>Direct Investments</b>- The Company may,
at its election, directly invest in private entities within the cannabis sector either through stock purchase agreements, debentures,
joint ventures or a hybrid of each through its wholly owned subsidiary GCC Investment Holdings, LLC. The Company’s planned
investments will focus on those entities whose near-term goals are to maximum shareholder value through the filing of an initial
public offering or a corporate event that takes the entity from private to public. Investments will be made through the Company’s
wholly owned subsidiary GCC Investment Holdings, LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 31, 2014, the Company entered into
a Licensing Agreement with Artemis Dispensing Technologies (“Artemis”) for the development and resell of an automated
dispensing product. Under the collaboration and license agreement, Artemis was to be responsible for the development of a high
end automated dispensing product. Upon launch and sales of the product, Artemis was to be responsible for the installation, training
and customer support for the hardware and software. The Company was to be responsible for direct sales, addition of key distributors
and sublicensing of specific territories within the U.S. Under the terms of the agreement, the Company was to pay to Artemis a
licensing fee in the total amount of $500,000 broken into tranches and based on development parameters. Artemis was to receive
a percentage of transaction fees generated on a monthly basis per unit. The Company was to receive revenue generated directly from
sales either though its website or sales staff, a royalty from sales generated through third party vendors/distributors or a percentage
of any sub-licenses sold. In addition, the Company was to have the first right of refusal to purchase a license for the use of
the same technology in other countries. The initial term of the Agreement expired December 31, 2016 and in the opinion of management
the Agreement is no longer in effect. Please <i>see</i> <b>NOTE C- ARTEMIS LICENSING AGREEMENT </b>for additional information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 16, 2016, Sylios Corp’s Board
of Directors voted to file a Notice of Conversion for its wholly owned subsidiary, The Greater Cannabis Company, LLC. The Notice
was filed with the State of Florida Division of Corporations on January 13, 2017 to convert The Greater Cannabis Company, LLC from
a limited liability company to a Florida for-profit corporation. The company name, The Greater Cannabis Company, LLC, was changed
to The Greater Cannabis Company, Inc. Included within the filing, The Greater Cannabis Company, Inc. filed its Articles of Incorporation
and authorized 500 million shares of Common stock and 10 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new entity, GCC Superstore, LLC. The Articles of Organization were
filed with the State of Florida on January 13, 2017 with a requested effective date of January 9, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 18, 2017, Sylios Corp filed a corporate
action with the Financial Industry Regulatory Authority (“FINRA”) to effect a partial spin-off of its wholly owned
subsidiary, The Greater Cannabis Company, Inc, through a stock dividend. Please <i>see</i> <b>NOTE A- BASIS OF PRESENTATION AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)</b> for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2017, the Company and Sylios
Corp. entered into a Anti-Dilution Agreement whereby at any time after the date of the Agreement, if the Company shall issue or
propose to issue any additional shares of the Company’s common stock, or warrants, options (excluding any options granted
to employees of the Company in accordance with any employee plans, now or hereinafter in effect) or other rights or instruments
of any kind convertible into or exercisable or exchangeable for shares of Common Stock, Sylios Corp. shall have the right to subscribe
for and to purchase at the same price per share that number of Additional Securities necessary to maintain a Fully-Diluted Ownership
Percentage or 19.99% of the Company’s issued and outstanding Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 7, 2017, Sylios Corp received notification
from the Financial Industry Regulatory Authority (“FINRA”) that they had received the necessary documentation to process
the corporate action requested by Sylios Corp and its transfer agent, Pacific Stock Transfer. The Company’s Payment Date
was set at March 10, 2017 and the distribution(s) were made consistent with such approval.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 10, 2017, the Company entered into
a Board of Directors Service Agreement with Jimmy Wayne Anderson to define the Director’s duties and compensation for serving
on the Company’s Board of Directors. Under the terms of the Agreement, the Director is to receive compensation in the amount
of Ten Thousand and no/100 dollars ($10,000) and 10,000 shares of the Company’s common stock payable on the last calendar
day of each quarter as long as Director continues to fulfill his duties and provides the services required.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2017, the Company entered into
a Collateral Agreement with Sylios Corp (“Borrower”) and SLMI Energy Holdings, LLC (“Lender”) whereby the
Company is released from any guaranty of the debt between Borrower and Lender. Lender agreed to release the UCC lien on the Company
effective upon execution of the Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2017, the Company entered into
a definitive Asset Acquisition Agreement (the “Agreement”) with Sylios Corp (“Sylios”), whereby the Company
acquired Sylios’ wholly owned subsidiary Bud Bank, LLC (“Bud Bank”). Under the Agreement, the Company is obligated
to pay Sylios a royalty of 10% of net sales proceeds generated by Bud Bank through its operations up to a total of $50,000 and
thereafter for perpetuity pay a royalty of 3% of net sales proceeds generated by Bud Bank through its operations. The transaction
closed on June 20, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2017, we launched our online store,
GCC Superstore, with limited merchandise such as pipes, vaporizers, CDB, hemp and cannabis related products.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 19, 2017, a Notice of Conversion was
filed for Bud Bank, LLC to effectively convert Bud Bank, LLC from a limited liability company to a Florida for-profit corporation.
The company name, Bud Bank, LLC, was changed to Bud Bank, Inc. Included within the filing, Bud Bank, Inc. filed its Articles of
Incorporation and authorized 250 million shares of Common stock and 5 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
a Convertible Promissory Note and Warrant and Subscription Agreement with Xeraflop Technologies, Inc. (“Xeraflop”).
Under the terms of the Agreement, the Company was to invest a total of One Hundred Thousand and NO/100 Dollars ($100,000) upon
a successful going public event. The Note was to accrue interest at 12% annually and mature on June 30, 2018. At the Company’s
election, the principal and interest could be converted into Series 2 common shares of Xeraflop with written notice. The Company
was also granted the right to purchase 20% warrant coverage based on the Company’s principal investment with a strike price
equivelant to the equity round financing. The Company’s investment in Xeraflop was dependent on the Company obtaining an
effective Registration Statement and successful 15C211 filing prior to the Closing of the financing round by Xeraflop. In the event
neither of these events occurred, the Company was not to be able to participate in this round of financing with Xeraflop. The Xeraflop
financing round closed prior to the Company receiving notification of its trading status. Therefore, the Company was not able to
participate in this round of financing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
an Advisory Agreement with MCAP, LLC (“MCAP”), whereby MCAP will act as the Company’s advisor in connection with
quoting the Company’s securities on OTCQB or OTCQX, Under the terms of the Agreement, the advisor’s services will include
rendering advice to the Company with respect to eligibility for becoming quoted on the OTCQB/OTCQX and educating, advising and
assisting the Company in complying with its ongoing OTCQB/OTCQX disclosure obligations under current federal and state securities
laws. The Company is to compensate MCAP a total of $15,000 with the first payment of $5,000 to be made upon execution of the Advisory
Agreement, the second payment of $5,000 to be made on or before August 2, 2017 and the final payment of $5,000 to be made upon
the Company’s acceptance on OTCQB/OTCQX. The Company made the initial payment of $5,000 on July 18, 2017. The Company has
not made the second or third payments due to MCAP, but the Agreement entered into between the parties is still in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 20, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new Florida limited liability company, GCC Investment Holdings, LLC.
The Articles of Organization were filed with the State of Florida on July 20, 2017. The new entity is a wholly owned subsidiary
of The Greater Cannabis Company, Inc. and will serve as the Company’s subsidiary to enter into direct cannabis related investments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Spin-Off</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 10, 2017, in connection with
a partial spin-off of the Company from Sylios Corp, the Company issued a total of 26,905,969 shares of its common stock. 5,378,476
shares were issued to Sylios Corp (representing 19.9% of the issued and outstanding shares of Company common stock after the spin-off)
and 21,527,493 shares were issued to the stockholders of record of Sylios Corp on February 3, 2017 on the basis of one share of
Company common stock for each 500 shares of Sylios Corp common stock held (representing 80.1% of the issued and outstanding shares
of Company common stock after the spin-off).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of The Greater Cannabis Company, Inc., and all of its wholly owned subsidiaries, Bud Bank, Inc., GCC Superstore, LLC
and GCC Investment Holdings, LLC. On March 10, 2017, the Company was spun-off from its former parent company, Sylios Corp, in a
stock dividend. Please <i>see</i> <b>NOTE A- BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)</b>
for further information. All intercompany accounts and transactions have been eliminated in consolidation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investments having an original maturity of
90 days or less that are readily convertible into cash are considered to be cash equivalents. For the period ended December 31,
2017, the Company had no cash equivalents.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Income Taxes</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with Accounting Standards Codification
(ASC) 740 - Income Taxes, the provision for income taxes is computed using the asset and liability method. The asset and liability
method measures deferred income taxes by applying enacted statutory rates in effect at the balance sheet date to the differences
between the tax basis of assets and liabilities and their reported amounts on the financial statements. The resulting deferred
tax assets or liabilities are adjusted to reflect changes in tax laws as they occur. A valuation allowance is provided when it
is more likely than not that a deferred tax asset will not be realized.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We expect to recognize the financial statement
benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in
an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount to be recognized in the financial
statements will be the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the
threshold, no financial statement benefit is recognized. As of December 31, 2017, we had no uncertain tax positions. We recognize
interest and penalties, if any, related to uncertain tax positions as general and administrative expenses. We currently have no
federal or state tax examinations nor have we had any federal or state examinations since our inception. To date, we have not incurred
any interest or tax penalties.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results
could differ from those estimates.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Financial Instruments and Fair Value of
Financial Instruments</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We adopted ASC Topic 820, <i>Fair Value Measurements
and Disclosures</i>, for assets and liabilities measured at fair value on a recurring basis. ASC Topic 820 establishes a common
definition for fair value to be applied to existing US GAAP that requires the use of fair value measurements that establishes a
framework for measuring fair value and expands disclosure about such fair value measurements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 820 defines fair value as the price that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. Additionally, ASC Topic 820 requires the use of valuation techniques that maximize the use of observable inputs
and minimize the use of unobservable inputs. These inputs are prioritized below:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 6%"><font style="font-size: 10pt">Level 1:</font></td>
<td style="width: 1%"> </td>
<td style="width: 93%; text-align: justify"><font style="font-size: 10pt">Observable inputs such as quoted market prices in active markets for identical assets or liabilities</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 2:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Observable market-based inputs or unobservable inputs that are corroborated by market data</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 3:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of financial assets and
liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured
on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and
liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. We had
no financial assets or liabilities carried and measured on a recurring or nonrecurring basis during the reporting periods.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Liabilities</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate stock options, stock warrants or
other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately
accounted for under the relevant sections of ASC Topic 815-40, <i>Derivative Instruments and Hedging: Contracts in Entity’s
Own Equity</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The result of this accounting treatment could
be that the fair value of a financial instrument is classified as a derivative instrument and is marked-to-market at each balance
sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value is
recorded in the statement of operations as other income or other expense. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Financial instruments
that are initially classified as equity that become subject to reclassification under ASC Topic 815-40 are reclassified to a liability
account at the fair value of the instrument on the reclassification date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-lived Assets</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets such as property and equipment
and intangible assets are periodically reviewed for impairment. We test for impairment losses on long-lived assets used in operations
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability
of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash
flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s
estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated
by management which could have a material effect on our reporting results and financial positions. Fair value is determined through
various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals,
as considered necessary.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Website Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Website costs are expensed as incurred. For
the years ended December 31, 2017 and 2016, website expense was $4,695 and $0, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Deferred Financing Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred financing costs represent costs incurred
in the connection with obtaining debt financing. These costs are amortized ratably and charged to financing expenses over the term
of the related debt.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equity Instruments Issued to Non-Employees
for Acquiring Goods or Services</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Issuances of our common stock or warrants for
acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants
or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is
reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently
large disincentive for nonperformance) or (ii) the date at which performance is complete.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although situations may arise in which counter
performance may be required over a period of time, the equity award granted to the party performing the service is fully vested
and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist if the instruments
are fully vested on the date of agreement, we determine such date to be the measurement date and will record the estimated fair
market value of the instruments granted as a prepaid expense and amortize such amount to expense over the contract period. When
it is appropriate for us to recognize the cost of a transaction during financial reporting periods prior to the measurement date,
for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock-Based Compensation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We account for share-based awards to employees
in accordance with ASC 718 “Stock Compensation”. Under this guidance, stock compensation expense is measured at the
grant date, based on the fair value of the award, and is recognized as an expense over the estimated service period (generally
the vesting period) on the straight-line attribute method. Share-based awards to non-employees are accounted for in accordance
with ASC 505-50 “Equity Based Payments to Non-Employees”, wherein such awards are expensed over the period in which
the related services are rendered.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Related Parties</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A party is considered to be related to us if
the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control
with us. Related parties also include our principal owners, our management, members of the immediate families of our principal
owners and our management and other parties with which we may deal if one party controls or can significantly influence the management
or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its
own separate interests. A party which can significantly influence the management or operating policies of the transacting parties,
or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that
one or more of the transacting parties might be prevented from fully pursuing its own separate interests, is also a related party.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales is recognized when
all of the following criteria are met: (1) persuasive evidence of an arrangement exists, (2) the price is fixed or determinable,
(3) collectability is reasonably assured, and (4) delivery has occurred.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Advertising Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
For the periods presented, we had no advertising costs.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss per Share</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute net loss per share in accordance
with FASB ASC 260. The ASC specifies the computation, presentation and disclosure requirements for loss per share for entities
with publicly held common stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share amounts is computed by
dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed
on the basis of the weighted average number of common shares and dilutive securities (such as stock options, warrants and convertible
securities) outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the
calculation. For the year ended December 31, 2017, the Company excluded 925,000 shares relating to convertible notes payable to
third parties (Please <i>see</i> <b>NOTE E - NOTES PAYABLE TO THIRD PARTIES </b>for further information) and 550,000 shares relating
to outstanding warrants (Please <i>see </i><b>NOTE H - ISSUANCES OF COMMON STOCK AND WARRANTS</b> for further information) from
the calculation of diluted shares outstanding as the effect of their inclusion would be anti-dilutive.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recently Enacted Accounting Standards</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which will supersede
nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when
promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects
to be entitled for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing
so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.
As amended by the FASB in July 2015, the standard is effective for annual periods beginning after December 15, 2017, and interim
periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application
of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach
with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote
disclosures). We are currently evaluating the impact of ASU 2014-09 on our future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02,
Leases (Topic 842), to provide guidance on recognizing lease assets and lease liabilities on the balance sheet and disclosing key
information about leasing arrangements, specifically differentiating between different types of leases. The core principle of Topic
842 is that a lessee should recognize the assets and liabilities that arise from all leases. The recognition, measurement, and
presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous GAAP. There
continues to be a differentiation between finance leases and operating leases. However, the principal difference from previous
guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the balance sheet.
The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The amendments will be effective
for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is
permitted. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period
presented using a modified retrospective approach. The modified retrospective approach includes a number of optional practical
expedients that entities may elect to apply. These practical expedients relate to the identification and classification of leases
that commenced before the effective date, initial direct costs for leases that commenced before the effective date, and the ability
to use hindsight in evaluating lessee options to extend or terminate a lease or to purchase the underlying asset. An entity that
elects to apply the practical expedients will, in effect, continue to account for leases that commence before the effective date
in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset
and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental
payments that were tracked and disclosed under previous GAAP. The Company is currently evaluating the impact of ASU 2016-02 on
its future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-08,
Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, to clarify the implementation guidance
on principal versus agent considerations and address how an entity should assess whether it is the principal or the agent in contracts
that include three or more parties. The effective date and transition requirements for these amendments are the same as the effective
date and transition requirements of ASU 2014-09 (discussed above). The Company is currently evaluating the impact of ASU 2016-08
on its future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2016, the FASB issued ASU No. 2016-10,
Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, to clarify the following
two aspects of Topic 606: 1) identifying performance obligations, and 2) the licensing implementation guidance. The effective
date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU 2014-09
(discussed above). The Company is currently evaluating the impact of ASU 2016-10 on its future financial statements.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE B - GOING CONCERN</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASC 205-40, we have the responsibility
to evaluate whether conditions and/or events raise substantial doubt about our ability to meet our future financial obligations
as they become due within one year after the date that the financial statements are issued. As required by this standard, our evaluation
shall initially not take into consideration the potential mitigating effects of our plans that have not been fully implemented
as of the date the financial statements are issued.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In performing the first step of this assessment,
we concluded that the following conditions raise substantial doubt about our ability to meet our financial obligations as they
become due. We have a history of net losses: as of March 31, 2018, we had a cumulative net loss of $1,001,300. For the three months
ended March 31, 2018, we used $14,443 cash from operating activities. As of March 31, 2018, we had $993 in cash available to fund
operations. We expect to continue to incur negative cash flows until such time as our operating segments generate sufficient cash
inflows to finance our operations and debt service requirements (which debt service approximates $180,000 through May 2019).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In performing the second step of this assessment,
we are required to evaluate whether our plans to mitigate the conditions above alleviate the substantial doubt about our ability
to meet our obligations as they become due within one year after the date that the financial statements are issued. Our future
plans include securing additional funding sources that may include establishing corporate partnerships, establishing licensing
revenue agreements, issuing additional convertible debentures and issuing public or private equity securities, including selling
common stock through an at-the-market facility (ATM).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There is no assurance that sufficient funds
required during the next year or thereafter will be generated from operations or that funds will be available through external
sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital
from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material
effect on the business. Furthermore, there can be no assurance that any such required funds, if available, will be available on
attractive terms or that they will not have a significant dilutive effect on the Company’s existing shareholders. We have
therefore concluded there is substantial doubt about our ability to continue as a going concern through May 2019.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements
have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. The accompanying consolidated financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities
that may result from the outcome of the uncertainty related to our ability to continue as a going concern.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE B - GOING CONCERN</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under ASC 205-40, we have the responsibility
to evaluate whether conditions and/or events raise substantial doubt about our ability to meet our future financial obligations
as they become due within one year after the date that the financial statements are issued. As required by this standard, our evaluation
shall initially not take into consideration the potential mitigating effects of our plans that have not been fully implemented
as of the date the financial statements are issued.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In performing the first step of this assessment,
we concluded that the following conditions raise substantial doubt about our ability to meet our financial obligations as they
become due. We have a history of net losses: as of December 31, 2017, we had a cumulative net loss of $915,997. For the year ended
December 31, 2017, we used $36,315 cash from operating activities. As of December 31, 2017, we had $993 in cash available to fund
operations. We expect to continue to incur negative cash flows until such time as our operating segments generate sufficient cash
inflows to finance our operations and debt service requirements (which debt service approximates $180,000 through April 2019).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In performing the second step of this assessment,
we are required to evaluate whether our plans to mitigate the conditions above alleviate the substantial doubt about our ability
to meet our obligations as they become due within one year after the date that the financial statements are issued. Our future
plans include securing additional funding sources that may include establishing corporate partnerships, establishing licensing
revenue agreements, issuing additional convertible debentures and issuing public or private equity securities, including selling
common stock through an at-the-market facility (ATM).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There is no assurance that sufficient funds
required during the next year or thereafter will be generated from operations or that funds will be available through external
sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital
from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material
effect on the business. Furthermore, there can be no assurance that any such required funds, if available, will be available on
attractive terms or that they will not have a significant dilutive effect on the Company’s existing shareholders. We have
therefore concluded there is substantial doubt about our ability to continue as a going concern through April 2019.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements
have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. The accompanying consolidated financial statements do not include any adjustments to reflect
the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities
that may result from uncertainty related to our ability to continue as a going concern.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE C - LOANS PAYABLE TO RELATED PARTIES
</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Loans payable to related parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Due to Chief Executive Officer</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,203</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">7,040</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Due to Sylios Corp and two subsidiaries of Sylios Corp</font></td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,042</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,862</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,245</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,902</font></td>
<td> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The loans are non-interest bearing and are
due on demand.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE D - LOANS PAYABLE TO RELATED PARTIES
</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Loans payable to related parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Due to Chief Executive Officer</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">7,040</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,477</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Due to Sylios Corp and two subsidiaries of Sylios Corp</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,862</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">284</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,902</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,761</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The loans are non-interest bearing and are
due on demand.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE E - NOTES PAYABLE TO RELATED PARTY
</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to related party consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%"><font style="font-size: 10pt">Promissory Note dated August 12, 2014 payable to Sylios Corp, interest at 3%</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">61,360</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">61,360</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Promissory Note dated March 31, 2017 payable to Sylios Corp, interest at 3%, due September 30, 2017</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,557</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,557</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">65,917</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">65,917</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE F - NOTES PAYABLE TO RELATED PARTY
</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to related party consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Promissory Note dated August 12, 2014 payable to Sylios Corp, interest at 3%</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">61,360</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">100,000</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Promissory Note dated March 31, 2017 payable to Sylios Corp, interest at 3%, due September 30, 2017</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,557</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">65,917</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100,000</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="margin: 0pt"></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE F - DERIVATIVE LIABILITY </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The derivative liability at March 31, 2018
and December 31, 2017 consisted of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">58,168</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">65,868</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note dated May 25, 2017. Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">95,260</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">96,580</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">16,929</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">18,381</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note dated September 14, 2017. Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">24,288</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">24,574</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Convertible Promissory Note dated January 9, 2018 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">27,296</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Allonge dated March 28, 2018 to the Convertible Promissory Note dated September 14, 2017 Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">14,898</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Allonge dated March 28, 2018 to the Convertible Promissory Note dated September 14, 2017. Please <i>see</i> <b>NOTE D – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">22,303</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total derivative liability</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">259,142</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">205,403</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Convertible Promissory Notes (the “Notes”)
and the warrants contain obligations to reduce the conversion price of the Notes and the exercise price of the Warrants in the
event that the Company sells, grants or issues any non-excluded shares, options, warrants or any convertible instrument at a price
below the conversion price of the Notes and the exercise price of the Warrants (“ratchet-down” provisions). The Notes
also contain a variable conversion feature based on the future trading price of the Company’s common stock. Therefore, the
number of shares of common stock issuable upon conversion of the Notes and exercise of the Warrants is indeterminate.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the derivative liability
was measured at the respective issuance dates and at March 31, 2018 using the Black Scholes option pricing model. Assumptions
used for the calculation of the derivative liability of the Notes at March 31, 2018 were (1) stock price of $0.25 per share, (2)
conversion price of $0.125 per share, (3) terms ranging from 2 months to 1 year, (4) expected volatility of 161%, and (5) risk
free interest rates ranging from 1.68% to 2.01%. Assumptions used for the calculation of the derivative liability of the warrants
at March 31, 2018 were (1) stock price of $0.25 per share, (2) exercise price of $0.50 per share, (3) terms ranging from 50 months
to 5 years, (4) expected volatility of 161%, and (5) risk free interest rates ranging from 2.42% to 2.56%.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE G - DERIVATIVE LIABILITY </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The derivative liability at December 31, 2017
consisted of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">65,868</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note. Please <i>see</i> <b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">96,580</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to EMET Capital Partners, LLC Please <i>see </i><b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">18,381</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Warrants issued to EMET in connection with the above Convertible Promissory Note. Please <i>see</i> <b>NOTE E – NOTES PAYABLE TO THIRD PARTIES for further information</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">24,574</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">          -</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total derivative liability</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">205,403</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Convertible Promissory Notes (the “Note”)
and the warrants contain obligations to reduce the conversion price of the Note and the exercise price of the Warrants in the event
that the Company sells, grants or issues any non-excluded shares, options, warrants or any convertible instrument at a price below
the conversion price of the Note and the exercise price of the Warrants (“ratchet-down” provisions). The Notes also
contain a variable conversion feature based on the future trading price of the Company’s common stock. Therefore, the number
of shares of common stock issuable upon conversion of the Notes and exercise of the Warrants is indeterminate. Accordingly, we
have recorded the fair value of the embedded conversion and exercise features as a derivative liability at the respective issuance
dates (total of $222,585 for the year ended December 31, 2017) and charged a total of $62,500 to debt discounts and a total of
$160,085 to other expense. The $17,182 decrease in the fair value of the derivative liability from the respective issuance dates
of the notes and warrants to the December 31, 2017 measurement date has been credited to other expense.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the derivative liability
was measured at the respective issuance dates and at December 31, 2017 using the Black Scholes option pricing model. Assumptions
used for the calculation of the derivative liability of the Notes at December 31, 2017 were (1) stock price of $0.25 per share,
(2) exercise price of $0.125 per share, (3) terms ranging from 5 months to 9 months, (4) expected volatility of 161%, and (5)
risk free interest rates ranging from 1.39% to 1.65%. Assumptions used for the calculation of the derivative liability of the
warrants at December 31, 2017 were (1) stock price of $0.25 per share, (2) exercise price of $0.50 per share, (3) terms ranging
from 53 months to 57 months, (4) expected volatility of 161%, and (5) risk free interest rates ranging from 2.11% to 2.13%.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE H - INCOME TAXES </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At March 31, 2018 the Company has available
for federal income tax purposes a net operating loss carry forward of approximately $133,792, of which $94,607 expires in the year
2037, that may be used to offset future taxable income. The Company has provided a valuation reserve against the full amount of
the net operating loss benefit, since in the opinion of management based upon the earnings history of the Company; it is more likely
than not that the benefits will not be realized. Due to possible significant changes in the Company’s ownership, the future
use of its existing net operating losses may be limited. All or a portion of the remaining valuation allowance may be reduced in
future years based on an assessment of earnings sufficient to fully utilize these potential tax benefits.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income taxes arise from the temporary
differences between financial statement and income tax recognition of net operating losses and other items. Loss carryovers are
limited under the Internal Revenue Code should a significant change in ownership occur.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s deferred taxes as of March
31, 2018 and December 31, 2017 consist of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="padding-bottom: 1.5pt; text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Non-Current deferred tax asset:</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"> </td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Net operating loss carry-forwards (a)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">28,096</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">19,867</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance (a)</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(28,096</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(19,867</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Net non-current deferred tax asset</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The income tax provision (benefit) differs
from the amount of income tax determined by applying the U.S. federal income tax rate of 21% for 2018 and 35% for 2017 to pretax
income due to the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td> </td>
<td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2017</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Expected tax at 21% for 2018 (a) and 35% for 2017</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">(17,914</font></td>
<td style="width: 1%"><font style="font-size: 10pt">)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$ </font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">(185,607</font></td>
<td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible stock-based compensation</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">525</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">183,750</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible expense from derivative liability</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,544</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible amortization of debt discounts</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,616</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Change in Valuation allowance</font></td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,229</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,857</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Provision for (benefit from) income taxes</font></td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 24px"> </td>
<td style="width: 24px"><font style="font-size: 10pt">(a)</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate was changed to 21% effective January 1, 2018. Accordingly, we reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $13,245 from $33,112 to $19,867 as of December 31, 2017.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All tax years remain subject to examination
by the Internal Revenue Service.<b> </b></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE I - INCOME TAXES </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2017, the Company has available
for federal income tax purposes a net operating loss carry forward of approximately $203,395, expiring in the year 2037, that may
be used to offset future taxable income. The Company has provided a valuation reserve against the full amount of the net operating
loss benefit, since in the opinion of management based upon the earnings history of the Company; it is more likely than not that
the benefits will not be realized. Due to possible significant changes in the Company’s ownership, the future use of its
existing net operating losses may be limited. All or a portion of the remaining valuation allowance may be reduced in future years
based on an assessment of earnings sufficient to fully utilize these potential tax benefits.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income taxes arise from the temporary
differences between financial statement and income tax recognition of net operating losses and other items. Loss carryovers are
limited under the Internal Revenue Code should a significant change in ownership occur.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s deferred taxes as of December
31, 2017 and December 31, 2016 consist of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Net operating loss carry-forwards</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">42,713</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">38,076</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(42,713</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(38,076</font></td>
<td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Net non-current deferred tax asset</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The income tax provision (benefit) differs
from the amount of income tax determined by applying the U.S. federal income tax rate of 35% to pretax income due to the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Expected tax at 35%</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">(282,523</font></td>
<td style="width: 1%"><font style="font-size: 10pt">)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$ </font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">(36,050</font></td>
<td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible stock-based compensation</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">186,375</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible expense from derivative liability</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">50,016</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible amortization of debt discounts</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">13,020</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Remeasurement of deferred income tax assets from 35% to 21% (a)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">28,475</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Change in Valuation allowance</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,637</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">36,050</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Provision for (benefit from) income taxes</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 24px"> </td>
<td style="width: 24px"><font style="font-size: 10pt">(a)</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate is 21% effective January 1, 2018. Accordingly, we have reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $28,475 from $71,188 to $42,713 as of December 31, 2017.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All tax years remain subject to examination
by the Internal Revenue Service.<b> </b></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE I - COMMITMENTS AND CONTINGENCIES</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Directors Service Agreement</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 10, 2017, the Company executed a Board
of Directors Service Agreement with Wayne Anderson. Under the terms of the Agreement, commencing April 1, 2017 the Company is to
pay Mr. Anderson $10,000 per quarter for which Mr. Anderson serves on the Board of Directors. In addition to cash compensation,
the Company is to issue Mr. Anderson 10,000 shares of its common stock for each quarter served. For the three months ended March
31, 2018, the Company expensed $12,500 (including $2,500 stock based) under the Agreement. At March 31, 2018 and December 31, 2017,
$50,000 due Mr. Anderson (including $10,000 stock based) and $37,500 due Mr. Anderson (including $7,500 stock based) is included
in “Accounts Payable and Accrued Expenses” in the Consolidated Balance Sheets at March 31, 2018 and December 31, 2017,
respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Occupancy</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From March 14, 2014 (inception) to March 31,
2018 and continuing, the Company has used office space provided by its former parent company, Sylios Corp, at no cost to the Company.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE J - COMMITMENTS AND CONTINGENCIES</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Directors Service Agreement</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 10, 2017, the Company executed a Board
of Directors Service Agreement with Wayne Anderson. Under the terms of the Agreement, commencing April 1, 2017 the Company is to
pay Mr. Anderson $10,000 per quarter for which Mr. Anderson serves on the Board of Directors. In addition to cash compensation,
the Company is to issue Mr. Anderson 10,000 shares of its common stock for each quarter served. For the year ended December 31,
2017, the Company expensed $37,500 (including $7,500 stock based) under the Agreement, which is included in “Accounts Payable
and Accrued Expenses” in the Consolidated Balance Sheet at December 31, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Occupancy</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From March 14, 2014 (inception) to December
31, 2017 and continuing, the Company has used office space provided by its former parent company, Sylios Corp, at no cost to the
Company.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE J - SUBSEQUENT EVENTS</b> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2018, the Company entered into negotiations
with a third party to outsource the day to day operations of its ecommerce division inclusive of the GCC Superstore. No definitive
terms have been reached, but both parties are working towards an Agreement. Under the proposed agreement, the GCC Superstore will
be redesigned and product categories expanded. As such, the Company has elected to temporarily take the GCC Superstore offline
while the cosmetic and backend work is being completed.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE K - SUBSEQUENT EVENTS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2018, the Company and Emet Capital
Partners, LLC (collectively, the “Parties”) entered into a Waiver Agreement pertaining to the Securities Purchase Agreements
entered into between the Parties dated May 25, 2017 and September 14, 2017 along with a Convertible Note issued by the Company
on each of the same dates (the “Notes”). Under the terms of the May 25, 2017 Note, the Company was to have a Going
Public Event no later than August 27, 2017. As of the date of the Waiver, the Company failed to be quoted on an eligible market.
Under the terms of the Waiver, the Company shall issue the Holder of the Notes a new Note (the “Waiver Note”) in the
amount of Twenty Thousand and no/100 dollars ($20,000). The Waiver Note is to bear interest at 5%, is due January 9, 2019 and is
convertible at the option of the holder into Company common stock at the Variable Conversion Price. Upon issuing the Waiver Note,
the Holder shall waive the event of default solely as related to timely have a Going Public Event. The Company did not receive
any funds for the issuance of the Waiver Note.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 28, 2018, the Company made an Allonge
to Emet Capital Partners, LLC to the Note due on September 14, 2018 and issued by the Company on September 14, 2017. The Principal
Amount as stated on the face of the Debenture shall be increased to $28,500 ($13,750 – original Principal Amount of the Debenture
+ $14,750 Allonge hereto the “New Principal”). The amendment to the Principal Amount due and owing on the Debenture
described herein notwithstanding, Holder does not waive interest that may have accrued at a default rate of interest and liquidated
damages, if any, that may have accrued on the Debenture through the date of this Allonge, which default interest and liquidated
damages, if any, remain outstanding and payable. As part of the transaction, EMET was also issued a warrant granting the holder
the right to purchase up to 98,600 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2018, the Company entered into negotiations
with a third party to outsource the day to day operations of its ecommerce division inclusive of the GCC Superstore. No definitive
terms have been reached, but both parties are working towards an Agreement. Under the proposed agreement, the GCC Superstore will
be redesigned and product categories expanded. As such, the Company has elected to temporarily take the GCC Superstore offline
while the cosmetic and backend work is being completed.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Nature of Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Greater Cannabis Company, Inc. (the “Company”)
was formed in March 2014 as a limited liability company under the name, The Greater Cannabis Company, LLC. The Company remained
a wholly owned subsidiary of Sylios Corp (“Sylios”) until March 2017. The Company’s business plan is to concentrate
on cannabis related investment and development opportunities through its online retail store, direct equity investments, joint
ventures, licensing agreements or acquisitions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s business model is divided
into four operating segments through the Company’s three wholly owned subsidiaries; Bud Bank, Inc., GCC Superstore, LLC and
GCC Investment Holdings, LLC:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <b>E-commerce</b>- Through the Company’s
wholly owned subsidiary, GCC Superstore, LLC, the Company has established an online store whose merchandise includes pipes, vaporizers,
grinders, hemp related products, CBD (Cannabidiol) related products and additional products focusing on the cannabis industry.
The online store, GCC Superstore, was opened in June 2017 and can be found at www.gccsuperstore.com. At present, the GCC Superstore
carries in excess of 1000 products from 20 suppliers and over 50 brands. The online store operates under a “drop-ship”
model which affords it the benefit of less capital expenditure on inventory. Please <i>see </i><b>NOTE J - SUBSEQUENT EVENTS </b>for
further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. <b>Advertising</b>- With the development
of the GCC Superstore, the Company will place directed advertising throughout the online store. Advertising will originate through
Google AdSense or direct-advertising sales by the Company. The company will also use social media outlets such as Facebook, Twitter
and Instagram in an effort to attract customers with product specific advertisements or posts.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <b>Licensing</b>- The Company is actively
seeking licensing opportunities in the cannabis sector, for intellectual property, products and dispensary means. At present, the
Company does not have any active licensing agreements. On July 31, 2014, the Company entered into a Licensing Agreement with Artemis
Dispensing Technologies for the development and resell of an automated dispensing product. Under the collaboration and license
agreement, Artemis was to be responsible for the development of a high end automated dispensing product. Upon launch and sales
of the product, Artemis was to be responsible for the installation, training and customer support for the hardware and software.
The Company was to be responsible for direct sales, addition of key distributors and sublicensing of specific territories within
the U.S. The initial term of the Agreement expired December 31, 2016 and in the opinion of management the Agreement is no longer
in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. <b>Direct Investments</b>- The Company may,
at its election, directly invest in private entities within the cannabis sector either through stock purchase agreements, debentures,
joint ventures or a hybrid of each through its wholly owned subsidiary GCC Investment Holdings, LLC. The Company’s planned
investments will focus on those entities whose near-term goals are to maximize shareholder value through the filing of an initial
public offering or a corporate event that takes the entity from private to public.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 16, 2016, Sylios Corp’s Board
of Directors voted to file a Notice of Conversion for its wholly owned subsidiary, The Greater Cannabis Company, LLC. The Notice
was filed with the State of Florida Division of Corporations on January 13, 2017 to convert The Greater Cannabis Company, LLC from
a limited liability company to a Florida for-profit corporation. The company name, The Greater Cannabis Company, LLC, was changed
to The Greater Cannabis Company, Inc. Included within the filing, The Greater Cannabis Company, Inc. filed its Articles of Incorporation
and authorized 500 million shares of Common stock and 10 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new entity, GCC Superstore, LLC. The Articles of Organization were
filed with the State of Florida on January 13, 2017 with a requested effective date of January 9, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 18, 2017, Sylios Corp filed a corporate
action with the Financial Industry Regulatory Authority (“FINRA”) to effect a partial spin-off of its wholly owned
subsidiary, The Greater Cannabis Company, Inc, through a stock dividend. Please <i>see</i> <b>NOTE A- NATURE OF OPERATIONS AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)</b> for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2017, the Company and Sylios
Corp. entered into a Anti-Dilution Agreement whereby at any time after the date of the Agreement, if the Company shall issue or
propose to issue any additional shares of the Company’s common stock, or warrants, options (excluding any options granted
to employees of the Company in accordance with any employee plans, now or hereinafter in effect) or other rights or instruments
of any kind convertible into or exercisable or exchangeable for shares of Common Stock, Sylios Corp. shall have the right to subscribe
for and to purchase at the same price per share that number of Additional Securities necessary to maintain a Fully-Diluted Ownership
Percentage of 19.99% of the Company’s issued and outstanding Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 7, 2017, Sylios Corp received notification
from the Financial Industry Regulatory Authority (“FINRA”) that they had received the necessary documentation to process
the corporate action requested by Sylios Corp and its transfer agent, Pacific Stock Transfer. The Company’s Payment Date
was set at March 10, 2017 and the distribution(s) were made consistent with such approval.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 10, 2017, the Company entered into
a Board of Directors Service Agreement with Jimmy Wayne Anderson to define the Director’s duties and compensation for serving
on the Company’s Board of Directors. Under the terms of the Agreement, the Director is to receive compensation in the amount
of Ten Thousand dollars ($10,000) and 10,000 shares of the Company’s common stock payable on the last calendar day of each
quarter as long as Director continues to fulfill his duties and provides the services required.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2017, the Company entered into
a Collateral Agreement with Sylios Corp (“Borrower”) and SLMI Energy Holdings, LLC (“Lender”) whereby the
Company was released from any guaranty of the debt between Borrower and Lender.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2017, the Company entered into
a definitive Asset Acquisition Agreement (the “Agreement”) with Sylios Corp (“Sylios”), whereby the Company
acquired Sylios’ wholly owned subsidiary Bud Bank, LLC (“Bud Bank”). Under the Agreement, the Company is obligated
to pay Sylios a royalty of 10% of net sales proceeds generated by Bud Bank through its operations up to a total of $50,000 and
thereafter for perpetuity pay a royalty of 3% of net sales proceeds generated by Bud Bank through its operations. The transaction
closed on June 20, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">   </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2017, we launched our online store,
GCC Superstore, with limited merchandise such as pipes, vaporizers, CDB, hemp and cannabis related products.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 19, 2017, a Notice of Conversion was
filed for Bud Bank, LLC to effectively convert Bud Bank, LLC from a limited liability company to a Florida for-profit corporation.
The company name, Bud Bank, LLC, was changed to Bud Bank, Inc. Included within the filing, Bud Bank, Inc. filed its Articles of
Incorporation and authorized 250 million shares of Common stock and 5 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
a Convertible Promissory Note and Warrant and Subscription Agreement with Xeraflop Technologies, Inc. (“Xeraflop”).
Under the terms of the Agreement, the Company was to invest a total of One Hundred Thousand Dollars ($100,000) upon a successful
going public event. The Note was to accrue interest at 12% annually and mature on June 30, 2018. At the Company’s election,
the principal and interest could be converted into Series 2 common shares of Xeraflop with written notice. The Company was also
granted the right to purchase 20% warrant coverage based on the Company’s principal investment with a strike price equivelant
to the equity round financing. The Company’s investment in Xeraflop was dependent on the Company obtaining an effective Registration
Statement and successful 15C211 filing prior to the Closing of the financing round by Xeraflop. In the event neither of these events
occurred, the Company was not to be able to participate in this round of financing with Xeraflop. The Xeraflop financing round
closed prior to the Company receiving notification of its trading status. Therefore, the Company was not able to participate in
this round of financing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
an Advisory Agreement with MCAP, LLC (“MCAP”), whereby MCAP will act as the Company’s advisor in connection with
quoting the Company’s securities on OTCQB or OTCQX, Under the terms of the Agreement, the advisor’s services will include
rendering advice to the Company with respect to eligibility for becoming quoted on the OTCQB/OTCQX and educating, advising and
assisting the Company in complying with its ongoing OTCQB/OTCQX disclosure obligations under current federal and state securities
laws. The Company is to compensate MCAP a total of $15,000 with the first payment of $5,000 to be made upon execution of the Advisory
Agreement, the second payment of $5,000 to be made on or before August 2, 2017 and the final payment of $5,000 to be made upon
the Company’s acceptance on OTCQB/OTCQX. The Company made the initial payment of $5,000 on July 18, 2017. The Company has
not made the second or third payments due to MCAP, but the Agreement entered into between the parties is still in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 20, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new Florida limited liability company, GCC Investment Holdings, LLC.
The Articles of Organization were filed with the State of Florida on July 20, 2017. The new entity is a wholly owned subsidiary
of The Greater Cannabis Company, Inc. and will serve as the Company’s subsidiary to enter into direct cannabis related investments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2018, the Company and Emet Capital
Partners, LLC (collectively, the “Parties”) entered into a Waiver Agreement pertaining to the Securities Purchase Agreements
entered into between the Parties dated May 25, 2017 and September 14, 2017 along with a Convertible Note issued by the Company
on each of the same dates (the “Notes”). Under the terms of the May 25, 2017 Note, the Company was to have a Going
Public Event no later than August 27, 2017. As of the date of the Waiver, the Company has failed to be quoted on an exchange. Under
the terms of the Waiver, the Company issued the Holder of the Notes a new Note (the “Waiver Note”) in the amount of
$20,000 and the Holder waived the event of default solely as related to timely have a Going Public Event. The Company did not receive
any funds for the issuance of the Waiver Note.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 28, 2018, the Company made an Allonge
to Emet Capital Partners, LLC to the Note due on September 14, 2018 and issued by the Company on September 14, 2017. The Principal
Amount as stated on the face of the Debenture shall be increased to $25,850.00 ($13,750.00 – original Principal Amount of
the Debenture + $12,100.00 Allonge hereto the “New Principal”). The amendment to the Principal Amount due and owing
on the Debenture described herein notwithstanding, Holder does not waive interest that may have accrued at a default rate of interest
and liquidated damages, if any, that may have accrued on the Debenture through the date of this Allonge, which default interest
and liquidated damages, if any, remain outstanding and payable. As part of the transaction, EMET was also issued a warrant granting
the holder the right to purchase up to 98,600 shares of the Company’s common stock at an exercise price of $.50 for a term
of 5-years.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Nature of Operations</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Greater Cannabis Company, Inc. was formed
in March 2014 as a limited liability company under the name, The Greater Cannabis Company, LLC. The Company remained a wholly owned
subsidiary of Sylios Corp until March 2017. The Company’s business plan is to concentrate on cannabis related investment
and development opportunities through its online retail store, direct equity investments, joint ventures, licensing agreements
or acquisitions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s business model is divided
into four operating segments through the Company’s three wholly owned subsidiaries; Bud Bank, Inc., GCC Superstore, LLC and
GCC Investment Holdings, LLC:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <b>E-commerce</b>- Through the Company’s
wholly owned subsidiary, GCC Superstore, LLC, the Company has established an online store whose merchandise includes pipes, vaporizers,
grinders, hemp related products, CBD (Cannabidiol) related products and additional products focusing on the cannabis industry.
The online store, GCC Superstore, was opened in June 2017 and can be found at www.gccsuperstore.com. At present, the GCC Superstore
carries in excess of 1000 products from 20 suppliers and over 50 brands. The online store operates under a “drop-ship”
model which affords it the benefit of less capital expenditure on inventory. Please <i>see </i><b>NOTE K - SUBSEQUENT EVENTS </b>for
further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. <b>Advertising</b>- With the development
of the GCC Superstore, the Company will place directed advertising throughout the online store. Advertising will originate through
Google AdSense or direct-advertising sales by the Company. The company will also use social media outlets such as Facebook, Twitter
and Instagram in an effort to attract customers with product specific advertisements or posts.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <b>Licensing</b>- The Company is actively
seeking licensing opportunities in the cannabis sector, for intellectual property, products and dispensary means. At present, the
Company does not have any active licensing agreements. On July 31, 2014, the Company entered into a Licensing Agreement with Artemis
Dispensing Technologies for the development and resell of an automated dispensing product. Under the collaboration and license
agreement, Artemis was to be responsible for the development of a high end automated dispensing product. Upon launch and sales
of the product, Artemis was to be responsible for the installation, training and customer support for the hardware and software.
The Company was to be responsible for direct sales, addition of key distributors and sublicensing of specific territories within
the U.S. The initial term of the Agreement expired December 31, 2016 and in the opinion of management the Agreement is no longer
in effect. Please <i>see</i> <b>NOTE C- ARTEMIS LICENSING AGREEMENT</b> for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. <b>Direct Investments</b>- The Company may,
at its election, directly invest in private entities within the cannabis sector either through stock purchase agreements, debentures,
joint ventures or a hybrid of each through its wholly owned subsidiary GCC Investment Holdings, LLC. The Company’s planned
investments will focus on those entities whose near-term goals are to maximum shareholder value through the filing of an initial
public offering or a corporate event that takes the entity from private to public. Investments will be made through the Company’s
wholly owned subsidiary GCC Investment Holdings, LLC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 31, 2014, the Company entered into
a Licensing Agreement with Artemis Dispensing Technologies (“Artemis”) for the development and resell of an automated
dispensing product. Under the collaboration and license agreement, Artemis was to be responsible for the development of a high
end automated dispensing product. Upon launch and sales of the product, Artemis was to be responsible for the installation, training
and customer support for the hardware and software. The Company was to be responsible for direct sales, addition of key distributors
and sublicensing of specific territories within the U.S. Under the terms of the agreement, the Company was to pay to Artemis a
licensing fee in the total amount of $500,000 broken into tranches and based on development parameters. Artemis was to receive
a percentage of transaction fees generated on a monthly basis per unit. The Company was to receive revenue generated directly from
sales either though its website or sales staff, a royalty from sales generated through third party vendors/distributors or a percentage
of any sub-licenses sold. In addition, the Company was to have the first right of refusal to purchase a license for the use of
the same technology in other countries. The initial term of the Agreement expired December 31, 2016 and in the opinion of management
the Agreement is no longer in effect. Please <i>see</i> <b>NOTE C- ARTEMIS LICENSING AGREEMENT </b>for additional information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 16, 2016, Sylios Corp’s Board
of Directors voted to file a Notice of Conversion for its wholly owned subsidiary, The Greater Cannabis Company, LLC. The Notice
was filed with the State of Florida Division of Corporations on January 13, 2017 to convert The Greater Cannabis Company, LLC from
a limited liability company to a Florida for-profit corporation. The company name, The Greater Cannabis Company, LLC, was changed
to The Greater Cannabis Company, Inc. Included within the filing, The Greater Cannabis Company, Inc. filed its Articles of Incorporation
and authorized 500 million shares of Common stock and 10 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 9, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new entity, GCC Superstore, LLC. The Articles of Organization were
filed with the State of Florida on January 13, 2017 with a requested effective date of January 9, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 18, 2017, Sylios Corp filed a corporate
action with the Financial Industry Regulatory Authority (“FINRA”) to effect a partial spin-off of its wholly owned
subsidiary, The Greater Cannabis Company, Inc, through a stock dividend. Please <i>see</i> <b>NOTE A- BASIS OF PRESENTATION AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)</b> for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 22, 2017, the Company and Sylios
Corp. entered into a Anti-Dilution Agreement whereby at any time after the date of the Agreement, if the Company shall issue or
propose to issue any additional shares of the Company’s common stock, or warrants, options (excluding any options granted
to employees of the Company in accordance with any employee plans, now or hereinafter in effect) or other rights or instruments
of any kind convertible into or exercisable or exchangeable for shares of Common Stock, Sylios Corp. shall have the right to subscribe
for and to purchase at the same price per share that number of Additional Securities necessary to maintain a Fully-Diluted Ownership
Percentage or 19.99% of the Company’s issued and outstanding Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 7, 2017, Sylios Corp received notification
from the Financial Industry Regulatory Authority (“FINRA”) that they had received the necessary documentation to process
the corporate action requested by Sylios Corp and its transfer agent, Pacific Stock Transfer. The Company’s Payment Date
was set at March 10, 2017 and the distribution(s) were made consistent with such approval.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 10, 2017, the Company entered into
a Board of Directors Service Agreement with Jimmy Wayne Anderson to define the Director’s duties and compensation for serving
on the Company’s Board of Directors. Under the terms of the Agreement, the Director is to receive compensation in the amount
of Ten Thousand and no/100 dollars ($10,000) and 10,000 shares of the Company’s common stock payable on the last calendar
day of each quarter as long as Director continues to fulfill his duties and provides the services required.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2017, the Company entered into
a Collateral Agreement with Sylios Corp (“Borrower”) and SLMI Energy Holdings, LLC (“Lender”) whereby the
Company is released from any guaranty of the debt between Borrower and Lender. Lender agreed to release the UCC lien on the Company
effective upon execution of the Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2017, the Company entered into
a definitive Asset Acquisition Agreement (the “Agreement”) with Sylios Corp (“Sylios”), whereby the Company
acquired Sylios’ wholly owned subsidiary Bud Bank, LLC (“Bud Bank”). Under the Agreement, the Company is obligated
to pay Sylios a royalty of 10% of net sales proceeds generated by Bud Bank through its operations up to a total of $50,000 and
thereafter for perpetuity pay a royalty of 3% of net sales proceeds generated by Bud Bank through its operations. The transaction
closed on June 20, 2017.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2017, we launched our online store,
GCC Superstore, with limited merchandise such as pipes, vaporizers, CDB, hemp and cannabis related products.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 19, 2017, a Notice of Conversion was
filed for Bud Bank, LLC to effectively convert Bud Bank, LLC from a limited liability company to a Florida for-profit corporation.
The company name, Bud Bank, LLC, was changed to Bud Bank, Inc. Included within the filing, Bud Bank, Inc. filed its Articles of
Incorporation and authorized 250 million shares of Common stock and 5 million shares of Preferred stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
a Convertible Promissory Note and Warrant and Subscription Agreement with Xeraflop Technologies, Inc. (“Xeraflop”).
Under the terms of the Agreement, the Company was to invest a total of One Hundred Thousand and NO/100 Dollars ($100,000) upon
a successful going public event. The Note was to accrue interest at 12% annually and mature on June 30, 2018. At the Company’s
election, the principal and interest could be converted into Series 2 common shares of Xeraflop with written notice. The Company
was also granted the right to purchase 20% warrant coverage based on the Company’s principal investment with a strike price
equivelant to the equity round financing. The Company’s investment in Xeraflop was dependent on the Company obtaining an
effective Registration Statement and successful 15C211 filing prior to the Closing of the financing round by Xeraflop. In the event
neither of these events occurred, the Company was not to be able to participate in this round of financing with Xeraflop. The Xeraflop
financing round closed prior to the Company receiving notification of its trading status. Therefore, the Company was not able to
participate in this round of financing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 17, 2017, the Company entered into
an Advisory Agreement with MCAP, LLC (“MCAP”), whereby MCAP will act as the Company’s advisor in connection with
quoting the Company’s securities on OTCQB or OTCQX, Under the terms of the Agreement, the advisor’s services will include
rendering advice to the Company with respect to eligibility for becoming quoted on the OTCQB/OTCQX and educating, advising and
assisting the Company in complying with its ongoing OTCQB/OTCQX disclosure obligations under current federal and state securities
laws. The Company is to compensate MCAP a total of $15,000 with the first payment of $5,000 to be made upon execution of the Advisory
Agreement, the second payment of $5,000 to be made on or before August 2, 2017 and the final payment of $5,000 to be made upon
the Company’s acceptance on OTCQB/OTCQX. The Company made the initial payment of $5,000 on July 18, 2017. The Company has
not made the second or third payments due to MCAP, but the Agreement entered into between the parties is still in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 20, 2017, the Company’s Board
of Directors voted to file Articles of Organization to form a new Florida limited liability company, GCC Investment Holdings,
LLC. The Articles of Organization were filed with the State of Florida on July 20, 2017. The new entity is a wholly owned subsidiary
of The Greater Cannabis Company, Inc. and will serve as the Company’s subsidiary to enter into direct cannabis related investments.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Spin-Off</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 10, 2017, in connection with
a partial spin-off of the Company from Sylios Corp, the Company issued a total of 26,905,969 shares of its common stock. 5,378,476
shares were issued to Sylios Corp (representing 19.99% of the issued and outstanding shares of Company common stock after the
spin-off) and 21,527,493 shares were issued to the stockholders of record of Sylios Corp on February 3, 2017 on the basis of one
share of Company common stock for each 500 shares of Sylios Corp common stock held (representing 80.01% of the issued and outstanding
shares of Company common stock after the spin-off).</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Spin-Off</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 10, 2017, in connection with
a partial spin-off of the Company from Sylios Corp, the Company issued a total of 26,905,969 shares of its common stock. 5,378,476
shares were issued to Sylios Corp (representing 19.9% of the issued and outstanding shares of Company common stock after the spin-off)
and 21,527,493 shares were issued to the stockholders of record of Sylios Corp on February 3, 2017 on the basis of one share of
Company common stock for each 500 shares of Sylios Corp common stock held (representing 80.1% of the issued and outstanding shares
of Company common stock after the spin-off).</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of The Greater Cannabis Company, Inc., and all of its wholly owned subsidiaries, Bud Bank, Inc., GCC Superstore,
LLC and GCC Investment Holdings, LLC. On March 10, 2017, the Company was spun-off from its former parent company, Sylios Corp,
in a stock dividend. Please <i>see</i> <b>NOTE A- NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)
</b>for further information. All intercompany accounts and transactions have been eliminated in consolidation.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Principles of Consolidation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of The Greater Cannabis Company, Inc., and all of its wholly owned subsidiaries, Bud Bank, Inc., GCC Superstore,
LLC and GCC Investment Holdings, LLC. On March 10, 2017, the Company was spun-off from its former parent company, Sylios Corp,
in a stock dividend. Please <i>see</i> <b>NOTE A- BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Spin-off)
</b>for further information. All intercompany accounts and transactions have been eliminated in consolidation.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying interim unaudited financial
statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”)
for interim financial statements and in the opinion of management contain all adjustments (consisting of only normal recurring
adjustments) necessary to present fairly, in all material respects, the Company’s consolidated financial position as of
March 31, 2018, and the results of its operations for the three months ended March 31, 2018 and 2017 and cash flows for the three
months ended March 31, 2018 and 2017. These statements reflect all normal and recurring adjustments that, in the opinion of management,
are necessary for a fair presentation of the information contained herein. The results of operations for the interim periods are
not necessarily indicative of the results that might be expected for future interim periods or for the full year ending December
31, 2018.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investments having an original maturity of
90 days or less that are readily convertible into cash are considered to be cash equivalents. For the periods presented, the Company
had no cash equivalents.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Investments having an original maturity of
90 days or less that are readily convertible into cash are considered to be cash equivalents. For the period ended December 31,
2017, the Company had no cash equivalents.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Income Taxes</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with Accounting Standards Codification
(ASC) 740 - Income Taxes, the provision for income taxes is computed using the asset and liability method. The asset and liability
method measures deferred income taxes by applying enacted statutory rates in effect at the balance sheet date to the differences
between the tax basis of assets and liabilities and their reported amounts on the financial statements. The resulting deferred
tax assets or liabilities are adjusted to reflect changes in tax laws as they occur. A valuation allowance is provided when it
is more likely than not that a deferred tax asset will not be realized.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We expect to recognize the financial statement
benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in
an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount to be recognized in the financial
statements will be the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the
threshold, no financial statement benefit is recognized. As of March 31, 2018, we had no uncertain tax positions. We recognize
interest and penalties, if any, related to uncertain tax positions as general and administrative expenses. We currently have no
federal or state tax examinations nor have we had any federal or state examinations since our inception. To date, we have not
incurred any interest or tax penalties.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Income Taxes</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with Accounting Standards Codification
(ASC) 740 - Income Taxes, the provision for income taxes is computed using the asset and liability method. The asset and liability
method measures deferred income taxes by applying enacted statutory rates in effect at the balance sheet date to the differences
between the tax basis of assets and liabilities and their reported amounts on the financial statements. The resulting deferred
tax assets or liabilities are adjusted to reflect changes in tax laws as they occur. A valuation allowance is provided when it
is more likely than not that a deferred tax asset will not be realized.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We expect to recognize the financial statement
benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in
an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount to be recognized in the financial
statements will be the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the
threshold, no financial statement benefit is recognized. As of December 31, 2017, we had no uncertain tax positions. We recognize
interest and penalties, if any, related to uncertain tax positions as general and administrative expenses. We currently have no
federal or state tax examinations nor have we had any federal or state examinations since our inception. To date, we have not
incurred any interest or tax penalties.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results
could differ from those estimates.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results
could differ from those estimates.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Financial Instruments and Fair Value of
Financial Instruments</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We adopted ASC Topic 820, <i>Fair Value Measurements
and Disclosures</i>, for assets and liabilities measured at fair value on a recurring basis. ASC Topic 820 establishes a common
definition for fair value to be applied to existing US GAAP that requires the use of fair value measurements that establishes a
framework for measuring fair value and expands disclosure about such fair value measurements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 820 defines fair value as the price that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. Additionally, ASC Topic 820 requires the use of valuation techniques that maximize the use of observable inputs
and minimize the use of unobservable inputs. These inputs are prioritized below:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 7%"><font style="font-size: 10pt">Level 1:</font></td>
<td style="width: 1%"> </td>
<td style="width: 92%; text-align: justify"><font style="font-size: 10pt">Observable inputs such as quoted market prices in active markets for identical assets or liabilities</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 2:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Observable market-based inputs or unobservable inputs that are corroborated by market data</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 3:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of financial assets and
liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured
on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and
liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. Except
for derivative liabilities, we had no financial assets or liabilities carried and measured on a recurring or nonrecurring basis
during the reporting periods.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Financial Instruments and Fair Value of
Financial Instruments</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We adopted ASC Topic 820, <i>Fair Value Measurements
and Disclosures</i>, for assets and liabilities measured at fair value on a recurring basis. ASC Topic 820 establishes a common
definition for fair value to be applied to existing US GAAP that requires the use of fair value measurements that establishes a
framework for measuring fair value and expands disclosure about such fair value measurements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 820 defines fair value as the price that
would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the
measurement date. Additionally, ASC Topic 820 requires the use of valuation techniques that maximize the use of observable inputs
and minimize the use of unobservable inputs. These inputs are prioritized below:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 6%"><font style="font-size: 10pt">Level 1:</font></td>
<td style="width: 1%"> </td>
<td style="width: 93%; text-align: justify"><font style="font-size: 10pt">Observable inputs such as quoted market prices in active markets for identical assets or liabilities</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 2:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Observable market-based inputs or unobservable inputs that are corroborated by market data</font></td></tr>
<tr style="vertical-align: top">
<td><font style="font-size: 10pt">Level 3:</font></td>
<td> </td>
<td style="text-align: justify"><font style="font-size: 10pt">Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of financial assets and
liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured
on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and
liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. We had
no financial assets or liabilities carried and measured on a recurring or nonrecurring basis during the reporting periods.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Liabilities</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate stock options, stock warrants or
other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately
accounted for under the relevant sections of ASC Topic 815-40, <i>Derivative Instruments and Hedging: Contracts in Entity’s
Own Equity</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The result of this accounting treatment could
be that the fair value of a financial instrument is classified as a derivative instrument and is marked-to-market at each balance
sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value
is recorded in the statement of operations as other income or other expense. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Financial instruments
that are initially classified as equity that become subject to reclassification under ASC Topic 815-40 are reclassified to a liability
account at the fair value of the instrument on the reclassification date.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Derivative Liabilities</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate stock options, stock warrants or
other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately
accounted for under the relevant sections of ASC Topic 815-40, <i>Derivative Instruments and Hedging: Contracts in Entity’s
Own Equity</i>.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The result of this accounting treatment could
be that the fair value of a financial instrument is classified as a derivative instrument and is marked-to-market at each balance
sheet date and recorded as a liability. In the event that the fair value is recorded as a liability, the change in fair value
is recorded in the statement of operations as other income or other expense. Upon conversion or exercise of a derivative instrument,
the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity. Financial instruments
that are initially classified as equity that become subject to reclassification under ASC Topic 815-40 are reclassified to a liability
account at the fair value of the instrument on the reclassification date.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-lived Assets</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets such as property and equipment
and intangible assets are periodically reviewed for impairment. We test for impairment losses on long-lived assets used in operations
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability
of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash
flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s
estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated
by management which could have a material effect on our reporting results and financial positions. Fair value is determined through
various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals,
as considered necessary.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-lived Assets</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets such as property and equipment
and intangible assets are periodically reviewed for impairment. We test for impairment losses on long-lived assets used in operations
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Recoverability
of an asset to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash
flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured
by the amount by which the carrying amount of the asset exceeds its fair value. Impairment evaluations involve management’s
estimates on asset useful lives and future cash flows. Actual useful lives and cash flows could be different from those estimated
by management which could have a material effect on our reporting results and financial positions. Fair value is determined through
various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals,
as considered necessary.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Website Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Website costs are expensed as incurred. For
the three months ended March 31, 2018 and 2017, website expense was $161 and $0, respectively.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Website Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Website costs are expensed as incurred. For
the years ended December 31, 2017 and 2016, website expense was $4,695 and $0, respectively.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Deferred Financing Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred financing costs represent costs incurred
in connection with obtaining debt financing. These costs are amortized ratably and charged to financing expenses over the term
of the related debt.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Deferred Financing Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred financing costs represent costs incurred
in the connection with obtaining debt financing. These costs are amortized ratably and charged to financing expenses over the
term of the related debt.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equity Instruments Issued to Non-Employees
for Acquiring Goods or Services</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Issuances of our common stock or warrants for
acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants
or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is
reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently
large disincentive for nonperformance) or (ii) the date at which performance is complete.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although situations may arise in which counter
performance may be required over a period of time, the equity award granted to the party performing the service may be fully vested
and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist if the
instruments are fully vested on the date of agreement, we determine such date to be the measurement date and will record the estimated
fair market value of the instruments granted as a prepaid expense and amortize such amount to expense over the contract period.
When it is appropriate for us to recognize the cost of a transaction during financial reporting periods prior to the measurement
date, for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Equity Instruments Issued to Non-Employees
for Acquiring Goods or Services</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Issuances of our common stock or warrants for
acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants
or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is
reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently
large disincentive for nonperformance) or (ii) the date at which performance is complete.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although situations may arise in which counter
performance may be required over a period of time, the equity award granted to the party performing the service is fully vested
and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist if the
instruments are fully vested on the date of agreement, we determine such date to be the measurement date and will record the estimated
fair market value of the instruments granted as a prepaid expense and amortize such amount to expense over the contract period.
When it is appropriate for us to recognize the cost of a transaction during financial reporting periods prior to the measurement
date, for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock-Based Compensation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We account for share-based awards to employees
in accordance with ASC 718 “Stock Compensation”. Under this guidance, stock compensation expense is measured at the
grant date, based on the fair value of the award, and is recognized as an expense over the estimated service period (generally
the vesting period) on the straight-line attribute method. Share-based awards to non-employees are accounted for in accordance
with ASC 505-50 “Equity Based Payments to Non-Employees”, wherein such awards are expensed over the period in which
the related services are rendered.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock-Based Compensation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We account for share-based awards to employees
in accordance with ASC 718 “Stock Compensation”. Under this guidance, stock compensation expense is measured at the
grant date, based on the fair value of the award, and is recognized as an expense over the estimated service period (generally
the vesting period) on the straight-line attribute method. Share-based awards to non-employees are accounted for in accordance
with ASC 505-50 “Equity Based Payments to Non-Employees”, wherein such awards are expensed over the period in which
the related services are rendered.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Related Parties</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A party is considered to be related to us
if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control
with us. Related parties also include our principal owners, our management, members of the immediate families of our principal
owners and our management and other parties with which we may deal if one party controls or can significantly influence the management
or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its
own separate interests. A party which can significantly influence the management or operating policies of the transacting parties,
or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that
one or more of the transacting parties might be prevented from fully pursuing its own separate interests, is also a related party.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Related Parties</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A party is considered to be related to us
if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control
with us. Related parties also include our principal owners, our management, members of the immediate families of our principal
owners and our management and other parties with which we may deal if one party controls or can significantly influence the management
or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its
own separate interests. A party which can significantly influence the management or operating policies of the transacting parties,
or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that
one or more of the transacting parties might be prevented from fully pursuing its own separate interests, is also a related party.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales is recognized when
all of the following criteria are met: (1) persuasive evidence of an arrangement exists, (2) the price is fixed or determinable,
(3) collectability is reasonably assured, and (4) delivery has occurred.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Revenue Recognition</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales is recognized when
all of the following criteria are met: (1) persuasive evidence of an arrangement exists, (2) the price is fixed or determinable,
(3) collectability is reasonably assured, and (4) delivery has occurred.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Advertising Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
For the periods presented, we had no advertising costs.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Advertising Costs</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred.
For the periods presented, we had no advertising costs.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss per Share</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute net loss per share in accordance
with FASB ASC 260. The ASC specifies the computation, presentation and disclosure requirements for loss per share for entities
with publicly held common stock.</p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share amounts is computed by
dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed
on the basis of the weighted average number of common shares and dilutive securities (such as stock options, warrants and convertible
securities) outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the
calculation. For the period ended March 31, 2018, the Company excluded 1,181,800 shares relating to convertible notes payable
to third parties (Please <i>see</i> <b>NOTE D - NOTES PAYABLE TO THIRD PARTIES </b>for further information) and 648,600 shares
relating to outstanding warrants (Please <i>see </i><b>NOTE G - ISSUANCES OF COMMON STOCK AND WARRANTS</b> for further information)
from the calculation of diluted shares outstanding as the effect of their inclusion would be anti-dilutive.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss per Share</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We compute net loss per share in accordance
with FASB ASC 260. The ASC specifies the computation, presentation and disclosure requirements for loss per share for entities
with publicly held common stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share amounts is computed by
dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed
on the basis of the weighted average number of common shares and dilutive securities (such as stock options, warrants and convertible
securities) outstanding. Dilutive securities having an anti-dilutive effect on diluted net loss per share are excluded from the
calculation. For the year ended December 31, 2017, the Company excluded 925,000 shares relating to convertible notes payable to
third parties (Please <i>see</i> <b>NOTE E - NOTES PAYABLE TO THIRD PARTIES </b>for further information) and 550,000 shares relating
to outstanding warrants (Please <i>see </i><b>NOTE H - ISSUANCES OF COMMON STOCK AND WARRANTS</b> for further information) from
the calculation of diluted shares outstanding as the effect of their inclusion would be anti-dilutive.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recently Enacted Accounting Standards</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which supersedes nearly
all prior revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised
goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled
for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, more judgment
and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. As amended by
the FASB in July 2015, the standard is effective for annual periods beginning after December 15, 2017, and interim periods therein,
using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard
in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the
cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures).
ASU 2014-09 has had no impact on our Financial statements for the three months ended March 31, 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02,
Leases (Topic 842), to provide guidance on recognizing lease assets and lease liabilities on the balance sheet and disclosing key
information about leasing arrangements, specifically differentiating between different types of leases. The core principle of Topic
842 is that a lessee should recognize the assets and liabilities that arise from all leases. The recognition, measurement, and
presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous GAAP. There
continues to be a differentiation between finance leases and operating leases. However, the principal difference from previous
guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the balance sheet.
The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The amendments will be effective
for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is
permitted. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period
presented using a modified retrospective approach. The modified retrospective approach includes a number of optional practical
expedients that entities may elect to apply. These practical expedients relate to the identification and classification of leases
that commenced before the effective date, initial direct costs for leases that commenced before the effective date, and the ability
to use hindsight in evaluating lessee options to extend or terminate a lease or to purchase the underlying asset. An entity that
elects to apply the practical expedients will, in effect, continue to account for leases that commence before the effective date
in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset
and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental
payments that were tracked and disclosed under previous GAAP. The Company is currently evaluating the impact of ASU 2016-02 on
its future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-08,
Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, to clarify the implementation guidance
on principal versus agent considerations and address how an entity should assess whether it is the principal or the agent in contracts
that include three or more parties. The effective date and transition requirements for these amendments are the same as the effective
date and transition requirements of ASU 2014-09 (discussed above). ASU 2016-08 has had no impact on our Financial statements for
the three months ended March 31, 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2016, the FASB issued ASU No. 2016-10,
Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, to clarify the following
two aspects of Topic 606: 1) identifying performance obligations, and 2) the licensing implementation guidance. The effective
date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU 2014-09
(discussed above). ASU 2016-10 has had no impact on our Financial statements for the three months ended March 31, 2018.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recently Enacted Accounting Standards</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers, which will supersede
nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when
promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects
to be entitled for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing
so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP.
As amended by the FASB in July 2015, the standard is effective for annual periods beginning after December 15, 2017, and interim
periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application
of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach
with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote
disclosures). We are currently evaluating the impact of ASU 2014-09 on our future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02,
Leases (Topic 842), to provide guidance on recognizing lease assets and lease liabilities on the balance sheet and disclosing key
information about leasing arrangements, specifically differentiating between different types of leases. The core principle of Topic
842 is that a lessee should recognize the assets and liabilities that arise from all leases. The recognition, measurement, and
presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous GAAP. There
continues to be a differentiation between finance leases and operating leases. However, the principal difference from previous
guidance is that the lease assets and lease liabilities arising from operating leases should be recognized in the balance sheet.
The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The amendments will be effective
for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, and early adoption is
permitted. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period
presented using a modified retrospective approach. The modified retrospective approach includes a number of optional practical
expedients that entities may elect to apply. These practical expedients relate to the identification and classification of leases
that commenced before the effective date, initial direct costs for leases that commenced before the effective date, and the ability
to use hindsight in evaluating lessee options to extend or terminate a lease or to purchase the underlying asset. An entity that
elects to apply the practical expedients will, in effect, continue to account for leases that commence before the effective date
in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset
and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental
payments that were tracked and disclosed under previous GAAP. The Company is currently evaluating the impact of ASU 2016-02 on
its future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2016, the FASB issued ASU No. 2016-08,
Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, to clarify the implementation guidance
on principal versus agent considerations and address how an entity should assess whether it is the principal or the agent in contracts
that include three or more parties. The effective date and transition requirements for these amendments are the same as the effective
date and transition requirements of ASU 2014-09 (discussed above). The Company is currently evaluating the impact of ASU 2016-08
on its future financial statements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2016, the FASB issued ASU No. 2016-10,
Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, to clarify the following
two aspects of Topic 606: 1) identifying performance obligations, and 2) the licensing implementation guidance. The effective
date and transition requirements for these amendments are the same as the effective date and transition requirements of ASU 2014-09
(discussed above). The Company is currently evaluating the impact of ASU 2016-10 on its future financial statements.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to third parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due May 25, 2018-less unamortized debt discount of $7,987 and $21,849 at March 31, 2018 and December 31, 2017, respectively (i)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">47,013</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,151</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due September 14, 2018-less unamortized debt discount of $6,236 and $9,702 at March 31, 2018 and December 31, 2017, respectively (ii)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">7,514</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,048</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Convertible Promissory Note dated January 9, 2018 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due January 9, 2019-less unamortized debt discount of $15,562 at March 31, 2018 (iii)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,438 </font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">- </font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Allonge to the Convertible Promissory Note dated September 14, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due September 14, 2018-less unamortized debt discount of $11,887 at March 31, 2018 (iv)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">213 </font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">- </font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td><font style="font-size: 10pt">Promissory Note dated March 28, 2017 payable to John T. Root, Jr., interest at 4%, due September 28, 2017, convertible into shares of common stock at a conversion price of $.001 per share.</font></td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">375</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">375</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><font style="font-size: 10pt">Total</font></td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">59,553</font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,574</font></td>
<td> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(i) On May 25, 2017, the Company executed a
Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $55,000 in exchange for $50,000 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (May 25, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the
lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up
to 440,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. As part of the Convertible
Note, the Company executed a Registration Rights Agreement (the “RRA”) dated May 25, 2017. Among other things, the
RRA provided for the Company to file a Registration Statement with the SEC covering the resale of shares underlying the Convertible
Note and the warrant and to have declared effective such Registration Statement. The Registration Statement was declared effective
by the Securities and Exchange Commission on August 31, 2017. Please <i>see </i><b>NOTE F - DERIVATIVE LIABILITY</b> for further
information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) On September 14, 2017, the Company executed
a Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $13,750 in exchange for $12,500 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (September 14, 2018) at the option of the holder at the Variable Conversion Price, which shall mean
the lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up
to 110,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please <i>see </i><b>NOTE
F - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(iii) On January 9, 2018, the Company executed
a Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $20,000 in exchange for entry into a Waiver Agreement pertaining to the Securities Purchase Agreements entered into between
the Parties dated May 25, 2017 and September 14, 2017 along with a Convertible Note issued by the Company on each of the same dates.
The Company received $0 cash from issuance of the Convertible Note. The Convertible Note is convertible, in whole or in part, at
any time and from time to time before maturity (January 9, 2019) at the option of the holder at the Variable Conversion Price,
which shall mean the lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price
(as defined). “Market Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty
(20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of
one (1) year and bears interest at 5% annually. Please <i>see </i><b>NOTE F - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(iv) On March 28, 2018, the Company made an
Allonge to the Convertible Debenture due September 14, 2018 (hereinafter the “Allonge”) to Emet Capital Partners,
LLC. The Principal Amount as stated on the face of the Debenture shall be increased to $25,850 ($13,750 – original Principal
Amount of the Debenture + $12,100 Allonge. The amendment to the Principal Amount due and owing on the Debenture described herein
notwithstanding, the Holder does not waive interest that may have accrued at a default rate of interest and liquidated damages,
if any, that may have accrued on the Debenture through the date of this Allonge, which default interest and liquidated damages,
if any, remain outstanding and payable. As part of the transaction, EMET was also issued a warrant granting the holder the right
to purchase up to 98,600 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please
<i>see </i><b>NOTE F - DERIVATIVE LIABILITY </b>for further information.</p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes payable to third parties consist of:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated May 25, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due May 25, 2018-less unamortized debt discount of $21,849 at December 31, 2017 (i)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">33,151</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Convertible Promissory Note dated September 14, 2017 payable to Emet Capital Partners, LLC (“EMET”), interest at 5%, due September 14, 2018-less unamortized debt discount of $9,702 at December 31, 2017 (ii)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">4,048</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Promissory Note dated March 28, 2017 payable to John T. Root, Jr., interest at 4%, due September 28, 2017, convertible into shares of common stock at a conversion price of $.001 per share.</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">375</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Total</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,574</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(i) On May 25, 2017, the Company executed a
Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $55,000 in exchange for $50,000 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (May 25, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the
lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up
to 440,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. As part of the Convertible
Note, the Company executed a Registration Rights Agreement (the “RRA”) dated May 25, 2017. Among other things, the
RRA provided for the Company to file a Registration Statement with the SEC covering the resale of shares underlying the Convertible
Note and the warrant and to have declared effective such Registration Statement. The Registration Statement was declared effective
by the Securities and Exchange Commission on August 31, 2017. Please <i>see </i><b>NOTE G - DERIVATIVE LIABILITY</b> for further
information.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(ii) On September 14, 2017, the Company executed
a Convertible Note (the “Convertible Note”) payable to Emet Capital Partners, LLC, (“EMET”) in the principal
amount of $13,750 in exchange for $12,500 cash. The Convertible Note is convertible, in whole or in part, at any time and from
time to time before maturity (September 14, 2018) at the option of the holder at the Variable Conversion Price, which shall mean
the lesser of (i) $0.25 (the “Fixed Conversion Price”); or (ii) 50% multiplied by the Market Price (as defined). “Market
Price” means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period
ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears
interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase
up to 110,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please <i>see </i><b>NOTE
G - DERIVATIVE LIABILITY </b>for further information.</p>
1181800
648600
925000
550000
525
183750
186375
4544
50016
4616
13020
8229
36050
1857
4637
0.21
0.35
0.21
0.35
13245
19867
33112
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The income tax provision (benefit) differs
from the amount of income tax determined by applying the U.S. federal income tax rate of 21% for 2018 and 35% for 2017 to pretax
income due to the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td> </td>
<td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Three Months Ended</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2018</b></font></td>
<td> </td>
<td> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>March 31, 2017</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt"><b>Expected tax at 21% for 2018 (a) and 35% for 2017</b></font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt"><b>$</b></font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt"><b>(17,914</b></font></td>
<td style="width: 1%"><font style="font-size: 10pt"><b>)</b></font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt"><b>$ </b></font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt"><b>(185,607</b></font></td>
<td style="width: 1%"><font style="font-size: 10pt"><b>)</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt"><b>Non-deductible stock-based compensation</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt"><b>525</b></font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt"><b>183,750</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt"><b>Non-deductible expense from derivative liability</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt"><b>4,544</b></font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt"><b>Non-deductible amortization of debt discounts</b></font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt"><b>4,616</b></font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt"><b>Change in Valuation allowance</b></font></td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>8,229</b></font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt"><b>1,857</b></font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt"><b>Provision for (benefit from) income taxes</b></font></td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
<td> </td>
<td> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
<td> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 24px"> </td>
<td style="width: 24px"><font style="font-size: 10pt">(a)</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate was changed to 21% effective January 1, 2018. Accordingly, we reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $13,245 from $33,112 to $19,867 as of December 31, 2017.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The income tax provision (benefit) differs
from the amount of income tax determined by applying the U.S. federal income tax rate of 35% to pretax income due to the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2016</b></font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 58%; text-align: justify"><font style="font-size: 10pt">Expected tax at 35%</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$</font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">(282,523</font></td>
<td style="width: 1%"><font style="font-size: 10pt">)</font></td>
<td style="width: 1%"> </td>
<td style="width: 1%"><font style="font-size: 10pt">$ </font></td>
<td style="width: 18%; text-align: right"><font style="font-size: 10pt">(36,050</font></td>
<td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible stock-based compensation</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">186,375</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible expense from derivative liability</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">50,016</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="text-align: justify"><font style="font-size: 10pt">Non-deductible amortization of debt discounts</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">13,020</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Remeasurement of deferred income tax assets from 35% to 21% (a)</font></td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">28,475</font></td>
<td> </td>
<td> </td>
<td> </td>
<td style="text-align: right"><font style="font-size: 10pt">-</font></td>
<td> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Change in Valuation allowance</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,637</font></td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="padding-bottom: 1.5pt"> </td>
<td style="border-bottom: black 1.5pt solid"> </td>
<td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">36,050</font></td>
<td style="padding-bottom: 1.5pt"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Provision for (benefit from) income taxes</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
<td style="padding-bottom: 2.5pt"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 24px"> </td>
<td style="width: 24px"><font style="font-size: 10pt">(a)</font></td>
<td style="text-align: justify"><font style="font-size: 10pt">As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate is 21% effective January 1, 2018. Accordingly, we have reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $28,475 from $71,188 to $42,713 as of December 31, 2017.</font></td></tr>
</table>
<p style="margin: 0pt"></p>
161
0
0
4695
36050
185607
282523
3
3
Amendment No. 1
20000
94607
50000
37500
On the basis of one share of Company common stock for each 500 shares of Sylios Corp common stock held
Accordingly, we reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $13,245 from $35,102 to $19,867 as of December 31, 2017.
Accordingly, we have reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $28,475 from $71,188 to $42,713 as of December 31, 2017.
375000
100000
100000
100000
26905969
26905969
29380969
100
24900
25000
100000
375
375
375000
38640
375
<p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE C - ARTEMIS LICENSING AGREEMENT</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the terms of the Agreement (Please see
<b>NOTE A – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </b>for further information), the Company
was to pay Artemis a licensing fee of $500,000 payable as follows: (1) $100,000 upon execution of the Agreement (which was paid
to Artemis in August 2014), (2) $100,000 in 60 days, (3) $100,000 upon Artemis’ delivery of a functioning prototype, and
(4) $200,000 after delivery of the prototype. Due to a lack of funds, the Company failed to pay the $100,000 due within 60 days
of the July 31, 2014 Agreement date. Artemis failed to deliver any prototype of the dispensing product to the Company. The initial
term of the Agreement expired December 31, 2016 and in the opinion of management the Agreement is no longer in effect.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2016 (expiration date of the
initial term of the Agreement), the Company reduced the carrying value of the Artemis Licensing Agreement capitalized costs from
$100,000 to $0 and recognized an expense provision for nonrecoverability of Artemis License Agreement costs of $100,000.</p>
100000
500000
500000
100000
100000
100000
200000
100000
0
100000
100000
222585
160085
17182
0.125
0.50
P5M
P9M
P53M
P57M
1.61
1.61
0.0139
0.0165
0.0211
0.0213
375000
98600
As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate was changed to 21% effective January 1, 2018. Accordingly, we reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $13,245 from $33,112 to $19,867 as of December 31, 2017.
On May 25, 2017, the Company executed a Convertible Note (the "Convertible Note") payable to Emet Capital Partners, LLC, ("EMET") in the principal amount of $55,000 in exchange for $50,000 cash. The Convertible Note is convertible, in whole or in part, at any time and from time to time before maturity (May 25, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the lesser of (i) $0.25 (the "Fixed Conversion Price"); or (ii) 50% multiplied by the Market Price (as defined). "Market Price" means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up to 440,000 shares of the Company's common stock at an exercise price of $.50 for a term of 5-years. As part of the Convertible Note, the Company executed a Registration Rights Agreement (the "RRA") dated May 25, 2017. Among other things, the RRA provided for the Company to file a Registration Statement with the SEC covering the resale of shares underlying the Convertible Note and the warrant and to have declared effective such Registration Statement. The Registration Statement was declared effective by the Securities and Exchange Commission on August 31, 2017. Please see NOTE F - DERIVATIVE LIABILITY for further information.
On September 14, 2017, the Company executed a Convertible Note (the "Convertible Note") payable to Emet Capital Partners, LLC, ("EMET") in the principal amount of $13,750 in exchange for $12,500 cash. The Convertible Note is convertible, in whole or in part, at any time and from time to time before maturity (September 14, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the lesser of (i) $0.25 (the "Fixed Conversion Price"); or (ii) 50% multiplied by the Market Price (as defined). "Market Price" means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up to 110,000 shares of the Company's common stock at an exercise price of $.50 for a term of 5-years. Please see NOTE F - DERIVATIVE LIABILITY for further information.
On January 9, 2018, the Company executed a Convertible Note (the "Convertible Note") payable to Emet Capital Partners, LLC, ("EMET") in the principal amount of $20,000 in exchange for entry into a Waiver Agreement pertaining to the Securities Purchase Agreements entered into between the Parties dated May 25, 2017 and September 14, 2017 along with a Convertible Note issued by the Company on each of the same dates. The Company received $0 cash from issuance of the Convertible Note. The Convertible Note is convertible, in whole or in part, at any time and from time to time before maturity (January 9, 2019) at the option of the holder at the Variable Conversion Price, which shall mean the lesser of (i) $0.25 (the "Fixed Conversion Price"); or (ii) 50% multiplied by the Market Price (as defined). "Market Price" means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears interest at 5% annually. Please see NOTE F - DERIVATIVE LIABILITY for further information.
On March 28, 2018, the Company made an Allonge to the Convertible Debenture due September 14, 2018 (hereinafter the "Allonge") to Emet Capital Partners, LLC. The Principal Amount as stated on the face of the Debenture shall be increased to $25,850 ($13,750 - original Principal Amount of the Debenture + $12,100 Allonge. The amendment to the Principal Amount due and owing on the Debenture described herein notwithstanding, the Holder does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Debenture through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up to 98,600 shares of the Company's common stock at an exercise price of $.50 for a term of 5-years. Please see NOTE F - DERIVATIVE LIABILITY for further information.
(a)As a result of the Tax Cuts and Jobs Act enacted on December 22, 2017, the United States corporate income tax rate is 21% effective January 1, 2018. Accordingly, we have reduced our deferred income tax asset relating to our net operating loss carryforward (and the valuation allowance thereon) by $28,475 from $71,188 to $42,713as of December 31, 2017.
On May 25, 2017, the Company executed a Convertible Note (the “Convertible Note�) payable to Emet Capital Partners, LLC, (“EMET�) in the principal amount of $55,000 in exchange for $50,000 cash. The Convertible Note is convertible, in whole or in part, at any time and from time to time before maturity (May 25, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the lesser of (i) $0.25 (the “Fixed Conversion Price�); or (ii) 50% multiplied by the Market Price (as defined). “Market Price� means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up to 440,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. As part of the Convertible Note, the Company executed a Registration Rights Agreement (the “RRA�) dated May 25, 2017. Among other things, the RRA provided for the Company to file a Registration Statement with the SEC covering the resale of shares underlying the Convertible Note and the warrant and to have declared effective such Registration Statement. The Registration Statement was declared effective by the Securities and Exchange Commission on August 31, 2017. Please see NOTE G - DERIVATIVE LIABILITY for further information.
On September 14, 2017, the Company executed a Convertible Note (the “Convertible Note�) payable to Emet Capital Partners, LLC, (“EMET�) in the principal amount of $13,750 in exchange for $12,500 cash. The Convertible Note is convertible, in whole or in part, at any time and from time to time before maturity (September 14, 2018) at the option of the holder at the Variable Conversion Price, which shall mean the lesser of (i) $0.25 (the “Fixed Conversion Price�); or (ii) 50% multiplied by the Market Price (as defined). “Market Price� means the lowest Trading Prices (as defined below) for the Common Stock during the twenty (20) Trading Day period ending on the last complete Trading Day prior to the Conversion Date. The Convertible Note has a term of one (1) year and bears interest at 5% annually. As part of the transaction, EMET was also issued a warrant granting the holder the right to purchase up to 110,000 shares of the Company’s common stock at an exercise price of $.50 for a term of 5-years. Please see NOTE G - DERIVATIVE LIABILITY for further information.